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ABSTRACT 
The human body consists of a dynamic collection of polymers, colloids, and gels. Therefore, 
most biological matter is soft matter, and many biomedical products, such as 3D cell culture 
platforms or nanocarriers for drug and imaging agent delivery, often consist mostly of soft 
matter.  Despite advances in these fields, concerns still exist regarding the function, 
reproducibility, and cost of soft matter systems for biomedical applications.  
To mitigate these concerns, we examined a variety of methods to utilize bioinspired self-
assembly to improve the function of 3D cell culture platforms and drug- and imaging agent-
loaded nanocarriers. The first part of this thesis investigates the role of a hydrophilic polymer in 
modulating the self-assembly of collagen molecules and the subsequent mechanical properties 
and permeability of the collagen gel. We further examined the combined effects of gel properties 
and external fluid flow on cancer cell phenotypes (Chapter 2). An additional study focuses on a 
3D printing technique to form multifunctional hydrogels (Chapter 3). In parallel, this thesis 
examined the thermodynamic effects of solvent quality and microfluidic mixer-based oil/water 
mixing rate on the size of nano-sized polymeric micelles and vesicles (Chapter 4). An additional 
study focuses on a self-assembled cluster of imaging agents for stem cell labeling (Chapter 5). 
Furthermore, this thesis explored a strategy to significantly increase the bioavailability of drug 
molecules in nanoparticles by driving self-assembly between alpha-tocopherol (Vitamin E) and 
amphiphilic polymers. The resulting system was functionalized to target and enhance treatment 
of venous neointial hyperplasia (VNH) that often occurs at arteriovenous fistula (AVF) of 
patients who are undergoing dialysis therapy (Chapter 6). Overall, the studies included herein 
will contribute broad knowledge to the fundamental science and applications of self-assembled 
systems for biomedical tools and products.  
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CHAPTER 1: INTRODUCTION 
1.1 Soft Matter in Biomedical Applications  
In the past 30 years, the study of soft matter---polymer networks, colloids, gels, and foams---
has emerged, forming a contrast to the “hard” matter which traditionally described the field of 
materials engineering. Many biological situations include some form of soft matter. For example, 
red blood cells can be considered deformable microparticles existing under various forms of 
shear.1 Cells synthesize and remodel a dynamic network of proteins stabilized by non-covalent 
and covalent interactions known as the extracellular matrix.2 DNA can be viewed as a polymer.3 
Thus, to prepare biomedical products (e.g., 3D cell cultures, nanoparticles), a knowledge of soft 
matter is required.  
 
1.2  3D Cell Culture: Background and Challenges  
In the past 30 years, it has been well-established that cells respond differently when grown in 
a three-dimensional (3D) environment than when grown in a two-dimensional petri dish.4–6  
These 3D cell culture environments often consist of a cross-linked network of water-retaining 
polymers, termed a hydrogel.7 These polymers can be synthetic or natural, and can be gelled 
using a variety of methods, such as radical polymerization.8 Countless studies have also 
demonstrated that the properties of this hydrogel, such as the mechanical stiffness or 
permeability of the hydrogel, strongly influence the phenotype of the cells grown in the 3D 
environment.9 Given the wide range of factors which can affect cell growth, the ideal hydrogel 
formulation would be able to tune multiple properties independent of one another. For example, 
an ideal hydrogel should present a range of stiffness values while keeping permeability constant. 
To this end, complex, hydrogels have been prepared, with actively tunable properties in response 
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to external stimuli.10–12 Simpler methods to tune hydrogel properties within an in vivo-like 
parameter space have yet to be explored, however. In addition, new methods to prepare simple 
hydrogels with dual functionalities are needed.  
 
1.3 Therapeutic Nanoparticles: Background and Challenges  
The field of nanomedicine has seen a dramatic amount of growth within the past 20 years, 
cumulating in the FDA approval of at least 25 nanomedicines for variety of diseases.13 
Nanomedicines offer the ability to deliver targeted drugs to diseased states in a highly selective 
manner, thus offering reduced systemic effects to the patient and a more effective use of each 
dose. Many nanomedicines are based on a polymeric nanocarrier, which can be made to degrade 
under certain conditions. Moreover, the size and surface properties of the nanocarrier can be 
tuned to enable delivery to different areas of the body. The vast amount of research in this field, 
however, often translates poorly into making clinical products.14 The existing hurdles in this field 
include: (1) poor control over particle morphology and size; (2) low encapsulation of hydrophilic 
and hydrophobic drugs, as well as imaging agents; and (3) particle trafficking to undesired areas.  
To solve these issues, a better understanding of the nanocarrier fabrication process is needed. 
In addition, new techniques and new chemistries are required to improve the encapsulation 
process of drug compounds with varying solubility. Moreover, methods to improve the 
trafficking of nanomaterials to different cells or different areas of the body are needed.  
 
1.4 Project Overview: Bioinspired Soft Matter Self-Assembly  
Nature provides a vast template for the design of self-assembled materials.15 Almost all 
aspects of living creatures, from the binding of a virus onto a cell membrane to the curvature of a 
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bacterial cell wall, are based on self-assembly. By relying on self-assembly, I have explored new 
methods to address the challenges regarding 3D cell culture and nanoparticle preparation.  
 
1.5 Self-Assembled Extracellular Matrices for Advanced 3D Cell Culture and Theranostic 
Designs  
 A significant concern in the field of hydrogel design is the incorporation of multiple 
functions or properties within a hydrogel. 3D cell culture in a hydrogel often requires different 
properties to be tuned independently of one another. For example, fluid flow in a hydrogel and 
hydrogel stiffness are often linked, and controlling one will change the other. In this manner, 
separating each hydrogel property from one another would lead to more rational 3D cell culture 
experiments. To this end, we played with the molecular assembly of collagen. Collagen gels are 
formed from the self-assembly of collagen molecules into a triple helical structure. This structure 
is stabilized by the presence of hydrogen bonding networks which connect the chains of the 
triple helix.16 These networks can be destabilized by the presence of certain hydrophilic 
molecules. Therefore, we hypothesized that incorporating polyethylene glycol into a self-
assembled collagen gel would soften the matrix stiffness while keeping hydraulic conductivity in 
the gel constant. We incorporated this gel system into a cell-microenvironment-on-a-chip 
(CMOC) system in order to grow cells under different pressure-driven flows and different 
stiffness environments. In this manner, the orthogonal effects of stiffness and flow on cancer 
malignancy can be observed in an in vitro platform. This project is covered in Chapter 2.  
 The incorporation of multiple functions is also a key design parameter when considering 
therapeutic or diagnostic hydrogels. Most notably, the field of theranostics requires therapeutics 
and diagnostics to be incorporated into the same nanoparticle or microparticle system.17 
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However, incorporating both functions---diagnostics and therapeutics—into one particle without 
having the diagnostic function interfere with the therapeutic function, and vice versa, remains a 
grand challenge in this field. To this end, we hypothesized that using a 3D printing technique 
would enable the incorporation of orthogonal functions within a hydrogel. This project is 
covered in Chapter 3.  
 
1.6 Bioinspired Design of Micelles and Polymeric Vesicles to Contain Drugs or Imaging 
Agents  
 In the past 15 years, a significant amount of research has been devoted to prepare nano-
sized vesicles with an amphiphilic polymeric bilayer or micelles with a hydrophobic core.18 
These nanostructures are often formed from the self-assembly of amphiphilic polymers under 
different aqueous conditions. Similar to cell membranes and organelles, these nanomaterials can 
package unique physiochemical functions into distinct compartments. By adding increasingly 
complex chemistries to these nanostructures, these bilayers and micelle structures can 
successfully encapsulate and release different molecules.20  
Forming these nanoparticles with a consistent size and morphology, however, remains a 
challenging task. It is likely that the self-assembly of these nanomaterials depends on the 
processing techniques used during self-assembly, as well as the solubility of the amphiphilic 
polymer in different conditions. To this end, we hypothesized that adding a one-step chemical 
modification to an amphiphilic polymer would enable improved solubility in an organic phase. 
This step would enable a wider parameter space in which to explore self-assembly. Therefore, by 
mixing this organic phase with water in either turbulent or laminar conditions at different mixing 
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rates, we hypothesized that nanostructures with different sizes could be formed. This concept is 
explored in Chapter 4. 
 More importantly, fine-tuned control over the trafficking of nanomaterials from the 
outside to the inside of the cell is still a significant concern in the nanoparticle field. Often, it is 
desirable to load as many nanoparticles into a cell as possible, as in the case of imaging agent-
based stem cell tracking. Here, a higher number of nanoparticles per cell considers to a higher 
diagnostic signal. To this end, we hypothesized that modulating the mechanical environment in 
which cells are grown would improve nanoparticle uptake. To test this hypothesis, we incubated 
stem cells with polyaspartamide-coated superparamagnetic iron oxide nanoparticles (SPIONs) 
clusters, and then gently stimulated the cells using an orbital shaker. The results of this study are 
included in Chapter 5.  
 Hydrophobic compounds represent a particularly unique challenge for nanoparticle 
delivery. Incorporating a high fraction of hydrophobic compounds into the nanoparticle interior 
is difficult, as most polymers used to fabricate nanoparticles are mostly hydrophilic in nature. To 
this end, we sought to fabricate vitamin E-loaded nanocarriers using an amphiphilic 
polyaspartamide polymer. We hypothesized that by tailoring the chemistry of this polymer, a 
nanocarrier would be formed with a size and function similar to that of chylomicrons, which are 
in vivo transporters of vitamin E. This topic is covered in Chapter 6.  
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 CHAPTER 2: A CELL-MICROENVIRONMENT-ON-A-CHIP (CMOC) 
SYSTEM ENABLING ORTHOGONAL CONTROL OF MATRIX 
SOFTNESS AND INTERSTITIAL FLOW FOR 3D CELL CULTURE1 
 
2.1 Introduction 
Cells are subject to and regulated by a complex, three dimensional (3D) extracellular 
microenvironment consisting of soluble factors, matrix stiffness, and interstitial fluid.1–4 In the past 
several decades, extensive efforts have been made to recapitulate the extracellular 
microenvironment in vitro. Doing so would provide both a better understanding of diverse cell 
behavior as well as an advanced screening method for newly developed medicine and biomedical 
                                                     
1 I would like thank my collaborators at Purdue University for their help, including Prof. Bumsoo 
Han, Kyenggon Shin, and Altug Ozcelikkale. I would like to thank Kong Lab members for their 
help as well, including Dr. Max Rich and Dr. Min Kyung Lee. I would also like to acknowledge 
the School of Chemical Sciences (SCS) graphics office for their assistance with figures. Special 
thanks are also due to the staff at the Frederick Seitz Materials Research Laboratory for help with 
scanning electron microscopy (SEM). This work was partially supported by Mayo Clinic and 
University of Illinois Alliance for Technology-Based Healthcare, National Science Foundation 
(STC-EBICS Grant CBET-0939511 to H.K.), NIH HHSN261201400021C (to B.H.), CTR 
Award from Indiana CTSI funded in part by UL1 TR000006 from NIH (to B.H.), a grant from 
Walther Cancer Foundation (to B.H.), and Dow graduate fellowship (to N.C).  
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products.5–8 As such, a series of in vitro cell culture platforms have been proposed to recapitulate 
in vivo extracellular tissue microenvironments.9–11   
Previous studies have largely focused on reproducing the extracellular matrix properties of 
different tissues using various hydrogel systems formulated for 3D cell culture.12,13 The gel 
properties including stiffness and cell adhesion ligand density were tailored to examine cellular 
response and to further regulate cellular activities. Separately, efforts have emerged to interrogate 
a biological role of interstitial fluid flow.14 Interstitial fluid flow has been shown to mechanically 
act on cells by producing a shear force on the cell surface. Alternatively, interstitial flow can also 
alter the autocrine gradients in the local cell environment, leading to changes in cell migration 
behavior.1 However, few efforts were made to systematically combine the effects of pressure-
driven interstitial fluid flow with those of matrix properties.  
In addition, increasing evidence suggests that matrix properties and interstitial flow separately 
influence the progressions of several acute, chronic, and malignant diseases.15–19 Of particular note 
is breast cancer, which responds to both mechanical properties of the ECM and interstitial flow 
through different mechanisms. Several in vivo studies have demonstrated that denser breast tissue 
is associated with a stronger risk for breast cancer.20. In vitro studies have further demonstrated 
that breast cancer cells possess a malignant phenotype when exposed to stiffer matrices. This 
transition to malignancy is largely regulated by mechanosensitive pathways (such as extracellular 
signal-regulated kinase (ERK)) which help the breast cancer cells sense their local mechanical 
environment.21,22  
Separately, several studies have demonstrated that interstitial flow in the cancer 
microenvironment can result in a metastatic breast cancer phenotype. It has been suggested that 
interstitial flow can alter the autologous chemokine gradients surrounding the cancer cell, in turn 
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leading to cell migration in the direction of flow.23  Additional studies have demonstrated that 
interstitial flow may also act mechanically on the cancer cell surface, in turn leading to more 
diverse changes in cell migration behavior.16  However, few studies were made to examine how 
these two factors—matrix stiffness and interstitial flow—can orchestrate malignancy in concert.  
To this end, this study presents a cell microenvironment-on-a-chip (CMOC) platform that can 
culture cells of interest in hydrogels with controlled stiffness and interstitial flow. Cell-laden 
collagen gels of controlled softness were fabricated in a microfluidic chip that was assembled to 
create a three-dimensional perfused cell culture environment. Non-reactive polyethylene glycol 
(PEG) was mixed with pre-gel collagen solution to control stiffness of the collagen gel over a 
desired range, while minimally altering hydraulic conductivity.  
During the cell culture period, cell-laden gels were continuously exposed to a pressure gradient 
that induced an interstitial flow of approximately 1 µm/s. In parallel, a separate set of cells were 
loaded into the gels with controlled stiffness but not exposed to flow. In this study, breast cancer 
cells were used to evaluate the function of the CMOC platform. Breast cancer malignancy was 
analyzed by quantifying the growth rate and expression levels of estrogen receptor-alpha (ER-α), 
integrin β1, and E-cadherin of tumor spheroids. ER-α is a specific breast cancer biomarker, and 
integrin upregulation and E-cadherin downregulation is associated with a malignant breast cancer 
phenotype. We anticipate the results of this study will enable the scale-down of complex tissue to 
a benchtop level, in turn having significant implications for fundamental cell studies and various 
biological applications.   
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2.2 Results 
2.2.1 Properties of collagen-PEG and pure collagen gels 
Collagen-PEG gels and pure collagen gels were prepared by changing the pH of a mixture of 
type I collagen and PEG from acidic to neutral.5,24 The mass ratio of the PEG to collagen (MPEG/Col) 
in the pre-gel solution was changed from 0 to 0.25 and 0.50. According to an oscillatory shear test, 
pure collagen gels presented a modulus of around 1 kPa. PEG added to the collagen pre-gel at 
MPEG/Col of 0.25 resulted in a softer gel, with a storage modulus of around 0.2 kPa (Figure 2.1). 
Further increase of MPEG/Col from 0.25 to 0.50 made no significant effects on the storage modulus 
of the resulting gel.   
Interestingly, the fibrous microstructure of the gel as determined with scanning electron 
microscopy (SEM) was minimally changed with the addition of PEG into the collagen gel (Figure 
2.2a). Regardless of the value of MPEG/Col, the pore area of the collagen fibers quantified with SEM 
images was around 0.1 µm2, and average fiber diameter was around 40 nm (Figure 2.2b and 2.2c).  
The hydraulic conductivity of the gel, which represents permeability of the gel under external 
pressure, was also quantified by fitting a stress versus strain curve obtained with a dynamic 
mechanical analyzer to the nonlinear poroelastic numerical model (Figure 2.3a and 2.3b).  This 
hydraulic conductivity value was estimated using Darcy's law by correlating the pressure 
difference across the channel and the average interstitial flow velocity as follows (Equation 2.1):  
𝜅 =
𝑢𝑎𝑣𝑔
Δ𝑃
           (2.1) 
 where κ is the hydraulic conductivity,  is the average interstitial fluid velocity based on 
average perfusion rate, and ΔP is the pressure difference across the channel. The hydraulic 
conductivity values were approximately 2×10-10 m2 Pa-1 s-1 at MPEG/Col of 0 and 0.25. The 
conductivity was increased to 6×10-10 m2 Pa-1 s-1 at MPEG/Col of 0.50 (Figure 2.3c).  
 
u
avg
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With these results, the pure collagen gel and the collagen-PEG gel with MPEG/Col of 0.50 were 
further used to assemble the CMOC platform. These two gel compositions displayed different 
elastic modulus (i.e., 1.0 vs 0.2 kPa) but similar mesh size.  However, external force changes 
hydraulic conductivity of the gel, thus potentially giving rise to differential effects of interstitial 
flow rate.  
Collagen or collagen-PEG gels were introduced into the CMOC platform via sequential filling 
of microchannels with pre-gel solution followed by incubation to activate gel formation in situ 
(Figure 2.4a) 25. Briefly, PDMS chips with three microchannels mimicking tissue sandwiched 
between two blood vessels were first prepared by standard photolithography techniques. Then, a 
syringe-driven flow of a pure collagen solution or collagen-PEG mixture filled the center part of 
the microchannels in the platform. Then, incubation of the chip loaded with collagen or collagen-
PEG solution at 37 ˚C for 1 h resulted in a stable gel system.  
The gels formed in the CMOC platform were perfused by the cell culture medium to 
recapitulate interstitial flow (Figure 2.4b).  In order to create the interstitial fluid flow, the gel was 
exposed to a pressure difference of 90 to 130 Pa across the 900 µm channel width (Figure 2.4c). 
Mean interstitial flow velocity was estimated by measuring the volume of culture medium perfused 
across the culture chamber for 24 h, as described below (Equation 2.2):  
𝑢avg =
𝑄𝑎𝑣𝑔
𝐴𝑎𝑣𝑔
           (2.2) 
where uavg is the averaged interstitial fluid velocity, Qavg is the perfused media volume, and Agel is 
the cross sectional area of the gel. Typically, with a pressure gradient of 90 to 130 Pa across the 
900 µm channel width, an average interstitial flow velocity of 1 µm/s was induced, which is 
comparable to the flow velocity in the interstitial tissue.16 
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2.2.2 Analyzing cell phenotype in the CMOC platform 
Finally, MCF-7 breast cancer cells were cultured in the gel of the CMOC platform. The mixture 
of cells and pre-gel solutions readily filled the center part of microchannels of the platform due to 
the minimal change in viscosity of the pre-gel solution. Further incubation of the chip at 37 ˚ C for 
1 h generated gel matrices that stably sequestered cells. External media flow minimally affected 
the overall structural integrity of the cell-laden gel matrices. 
According to micrographs of cells in the gels, cells loaded in both pure collagen gel and softer 
collagen-PEG gel underwent active proliferation and formed a 3D spheroid (Figure 2.5a). For the 
first four days of cell culture, no significant change in the surface area of cell spheroids was 
observed between the two gel conditions. In contrast, at day 6, cell spheroids formed in the softer 
collagen-PEG gels presented 1.5-fold larger cross-sectional area than those cultured within the 
stiffer pure collagen gel (Figure 2.5b). Interstitial fluid flow made a minimal difference of the 
cross-sectional area of spheroids, regardless of the gel stiffness.  
More interestingly, the hydraulic conductivity of the cell-laden gel decreased during the cell 
growth.  As mentioned previously, the conductivity of acellular gel was 1×10-10 m2 Pa-1 s-1, 
increasing to 1×10-11 m2 Pa-1 s-1 after day 6.  
After 6 days of growth, the cell spheroids were stained to assess cellular expression levels of 
estrogen receptor (ER)-α, integrin β1, and E-cadherin (Figure 2.6). It is well-known that breast 
cancer cells express ER-α in the cell nucleus.26,27 In addition, integrin β1 correlates with the degree 
of cellular invasion into a matrix, where E-cadherin expression correlates with cell-cell adhesion 
and a less invasive phenotype.28–32 The expression levels were then quantified based on the 
positively stained pixel intensity of the resulting fluorescent image. In the absence of interstitial 
fluid flow, spheroids formed in the softer collagen-PEG gels displayed two-fold higher ER-α 
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expression level than those in the stiffer collagen gel (Figure 2.6a). In contrast, interstitial fluid 
flow normalized the effect of matrix softness on ER-α expression.   
In addition, gel stiffness significantly influenced cellular expression of integrin β1, while 
perfusion modulated expression of both integrin β1 and E-cadherin. In particular, spheroids 
cultured in the softer collagen-PEG gel presented almost 10-fold higher integrin expression in the 
absence of interstitial fluid flow. This inverse dependency of the integrin expression level on the 
gel stiffness was normalized by perfusing the gel, as exhibited with the decrease of the integrin 
expression level of spheroids in the softer collagen-PEG gels (Figure 2.6b). In contrast, E-cadherin 
expression level of spheroids formed in the softer collagen-PEG gel was comparable to those 
formed in the pure collagen gel. The perfusion of the gel increased cellular expression of E-
cadherin regardless of the gel stiffness (Figure 2.6c). 
 
2.3 Discussion 
Using the CMOC platform, this study demonstrated combined effects of gel stiffness 
controlled with MPEG/Col and interstitial flow rate on malignancy of cancer cells. The role of PEG 
in significantly modulating gel stiffness is related to the intermolecular forces responsible for 
collagen gel formation. Collagen gels consist of fibers self-assembled from two or more 
nanometer-sized fibrils.33,34 It has been well-agreed that the collagen fibril structure is stabilized 
by the orchestration of intermolecular attractive and repulsive forces.35,36 The main attractive force 
involves hydrogen bonding between peptides and water molecules which bridge peptides on 
different collagen chains (Figure 2.7a). Previous computational and experimental studies have 
demonstrated that hydrogen bonds between collagen molecules and water molecules contribute to 
making stable collagen fibrils.37,38 With the addition of PEG to the pre-gel collagen solution, PEG 
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likely associated with water molecules via hydrogen bonds, thus reducing water bridges between 
collagen molecules (Figure 2.7b).  
Due to the decreased hydrogen bonds between collagen and water molecules, collagen 
molecules may associate loosely to each other, in turn inhibiting fibrillogenesis and thus forming 
more deformable collagen fibers. As this softening is occurring within a fibril-level, significant 
microscopic changes in gel mesh size are minimal.  
Similarly, previous studies have reported that sugars or other hydrophilic molecules can 
negatively impact the self-association between collagen molecules by disrupting the hydrogen 
bonds between collagen and water, in turn leading to fibril disorganization.39,40 The specific role 
of PEG in influencing collagen structure can be elucidated with further study. Nonetheless, this 
study is among the first to regulate bulk mechanical properties of a collagen gel by mediating 
collagen-water hydrogen bonds. This approach to forming a collagen hydrogel with tunable 
properties relies primarily on tuning the non-covalent interactions that form the self-assembled gel 
network, thus avoiding the complex chemistry required in previous approaches.41,42  
Another interesting feature of this gel formulation is the dependency of hydraulic conductivity 
and gel stiffness when the gel is subject to external pressure.43 More interestingly, the mesh size 
of the gel characterized with the electron microscopic image was independent of the gel stiffness.44 
This result suggests that interstitial flow rate would be higher with the softer collagen-PEG gel, 
likely because the external force can deform the gel structure more significantly. This 
interpretation is supported by decrease of the hydraulic conductivity throughout cell culture. As 
the cells proliferate in the gel, the gel matrix becomes more compact due to synthesis of 
extracellular matrix proteins. 
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This study further demonstrated that perfusion in the CMOC system significantly shifts breast 
cancer cells to a less malignant phenotype. This trend was demonstrated by a decrease in integrin 
β1 and an increase in E-cadherin. When considering the orthogonal mechanical cues presented to 
the cells, it is likely that the perfusion-driven difference of interstitial flow rate between two gel 
conditions, represented with hydraulic conductivity, neutralizes effects of matrix stiffness on 
cancer cell malignancy. These results uniquely differs from previous studies that reported the 
strongly interconnected relationship between cancer malignancy and matrix stiffness.45  
This disparity from previous studies may be caused by the unique feature of the CMOC 
platform which allowed integrative controls of matrix stiffness and perfusion in a physiologically 
relevant range.46 Besides, the biological effects of perfusion may be also mitigated by the type of 
matrix used for cell culture because of the different binding affinities between soluble factors and 
the extracellular matrix.47 More specific phenotypic changes may be realized as the interstitial flow 
rate is controlled over a broader range.  
With controlled hydrogel properties and interstitial fluid flow rates, increasing combinations 
of in vivo-like mechanical environments could be scaled down to a benchtop level. As an initial 
application, the microfluidic platform enabled us to demonstrate how matrix softness and 
interstitial fluid flow orchestrate the malignancy of breast cancer cells. In the near future, additional 
mechanical factors (e.g., pulsatile flow) and soluble factors (e.g., matrix metalloproteinases) can 
be incorporated into this system, in order to reproduce a more in vivo-like environment.48–50  
In addition, hydrogels with transient properties (e.g., a gel that softens or stiffens in response 
to a certain chemical factor) could be added to prepare a “smart” CMOC system. By coupling 
facile hydrogel formulations and standard lithography-based PDMS chips, we envision this 
CMOC platform can be used for studying a wide array of chronic and malignant diseases, 
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ultimately leading to a full “body-on-a-chip” enabling rapid but precise drug screening as well as 
the development of personalized medicines. 
 
2.4 Conclusion 
In conclusion, this study demonstrated a unique CMOC platform that allows us to integrate 
orthogonal effects of matrix mechanics and perfusion on cells cultured in a 3D matrix. The 
mechanical stiffness of the cell-laden collagen gel installed in the CMOC platform was controlled 
by adding controlled amounts of PEG during the gelation process. The presence of PEG likely 
reduces hydrogen bonds between collagen and water molecules, thus resulting in softer collagen 
fibers. The gel formulation also enabled us to modulate hydraulic conductivity, which influences 
interstitial flow rate under perfusion. According to breast cancer cell culture studies with the 
CMOC platform, perfusion minimized the role of matrix softness in upregulating breast cancer 
malignancy, likely due to more significant increases in shear stress on the cell membrane and the 
reorganization of soluble factors in the softer gel. We envisage that the CMOC platform would be 
useful to better understanding and regulating the effects of multifaceted extracellular 
microenvironments on the genotypic and phenotypic activities of a wide array of cells. 
 
2.5 Materials and Methods  
All components were purchased from Sigma-Aldrich unless noted otherwise.  
 
2.5.1 Preparation of collagen-PEG and pure collagen gels 
To prepare a pure collagen gel (MPEG/Col = 0), an aqueous mixture of phosphate buffered saline 
(PBS, Corning), NaOH, fetal bovine serum (FBS, Invitrogen) was mixed with rat tail type I 
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collagen (Fisher) at 4 ˚C. Then, the mixture was incubated at 37 ˚ C for at least 30 minutes. To 
prepare collagen-PEG gels, a desired amount of PEG (MW 7,500, Polysciences) solution was 
added to the pre-gelled collagen solution mixed with PBS, NaOH, and FBS. A sample receipe for 
a collagen gel is noted below in Table 2.1.  It should be noted that the rat tail collagen solution has 
a different concentration from batch to batch. The volume of collagen solution added was adjusted 
such that the final concentration is 6 mg/mL in the gel. 
 
2.5.2 Rheological measurement of collagen-PEG gels 
Pre-gel collagen solutions with MPEG/Col of 0, 0.25, and 0.5 were prepared as described 
previously. Then, 200 µL of the pre-gel solution was quickly loaded onto the bottom plate of a 
parallel plate (diameter = 22 mm) configuration on a rheometer (DHR-3, TA Instruments). Once 
gels formed between the two parallel plates, a frequency sweep from 0.1 to 10 Hz was applied to 
the gels at 0.1 % strain. The storage modulus value measured at 1 Hz was reported as the storage 
modulus value for a given condition. At least three replicates were tested per gel.  
 
2.5.3 Measurement of hydraulic conductivity 
Hydraulic conductivity of the collagen matrices were determined using a dynamic 
mechanical analyzer (DMA, TA Instruments Q800) and post-analysis based on poroelastic 
theory. Collagen gels were prepared in a disk shape with a 12 mm diameter and a 3 mm 
thickness inside a polydimethylsiloxane (PDMS) mold.  A sample was transferred to the DMA 
sample holder. Then, the gel was subject to a ramp load from 0 to 10 mN at a rate of 2 mN/min 
speed. The sample thickness was determined by a DMA clamp position at the beginning of the 
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ramp load, and this thickness was used as the reference thickness for strain computation.  Stress 
was calculated by dividing the measured force by the sample area.  
Assuming the collagen gel is approximated as a poroelastic material, its stress-strain 
relationship during unconfined compression can be described by an analytic solution reported by 
Armstrong.51,52  By performing non-linear numerical curve-fitting of the measured stress-strain 
data with respect to the analytic solution, the hydraulic conductivity and shear modulus were 
determined.  The results were obtained using an optimization routine developed in MATLAB.  
An R2 coefficient of correlation greater than 0.994 was considered a good fit. 
 
2.5.4 Scanning electron microscope (SEM) imaging of collagen-PEG and pure collagen gels 
Collagen-PEG and collagen gels were prepared as described before. Approximately 100-200 
uL of the pregel solution was plated on a glass slide, and then incubated at 37 ˚ C for at least 20 
minutes. Then, the collagen gels were incubated in PBS for at least 30 minutes. Afterwards, the 
gels were fixed in 3.7 % (v/v) paraformaldehyde, and then washed with DI water four times, 
with each wash lasting for 15 minutes. Then, 30, 50, 70, and 100 % (v/v) ethanol solutions were 
each added to the gels for 30 minutes, in order to gradually dehydrate the gels. Gels were then 
dried using a critical point dryer, and then coated with a thin layer of gold (EMITECH 575). 
Scanning electron microscope images (Hitachi S4800) images were taken with at an accelerating 
voltage of 10 kV, and a working distance of around 9 mm. 
To measure the pore area of the collagen gels, SEM images were opened in ImageJ (NIH), 
and an automatic threshold was applied to remove background features. Then, at least 10 areas 
were measured, taken across multiple images. Fiber size was measured from the raw SEM 
images, without taking a background correction.  
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2.5.5 Cell culture of MCF-7 on microfluidic devices 
MCF-7 cells (ATCC) were trypsinized, mixed with pre-gel collagen solutions as previously 
described, and then loaded into a pre-chilled CMOC. The CMOC design was prepared as 
previously described.25 The final concentration of cells was 107 cells/mL. Once the culture 
chamber was filled with collagen solution, the CMOC was incubated for 1 h at 37 ˚ C and 5 % 
CO2. After gel formation, culture medium was perfused using culture medium reservoirs 
connected to CMOC ports. Then, the cells were incubated at 37 ˚ C and 5 % CO2 and cultured in 
the CMOC for 6 days with culture medium replaced every 24 h. Interstitial flow was driven by 
pressure differences between the two perfusion channels. The tumor growth rate was quantified 
by measuring surface area of spheroids captured with brightfield images acquired with an 
inverted microscope (IX71, Olympus). Total cellular area was obtained using ImageJ software, 
then divided by the number of cell clumps in the region of interest to acquire mean cell clump 
area. Then, the mean cell clump area was normalized by mean cell clump area on day 0 
(Equation 2.3): 
.    (2.3) 
Additionally, cells growing on top of the glass slide were rejected and only the area of 3D cell 
cluster within extracellular matrix was included in this analysis. 
 
2.5.6 Immunostaining for estrogen receptor-alpha (ER-α)   
To stain for ER-α, cells in the microfluidic chips were fixed in methanol-free 3.7 % 
paraformaldehyde for at least 24 h at room temperature. Then, cells were blocked with a PBS 
solution containing 10 mg/mL bovine serum albuminum (BSA), 10 % (v/v) fetal bovine serum 
(FBS), and 0.1 % (v/v) Tween-20 for at least 12 h. The blocking solution was perfused from both 
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sides of the chip, with at least 200 µL of solution used in each port. Note that for these chips, a 
volume of 200 µL in one port corresponds to a height of approximately 26 mm, and a volume of 
100 µL in one port corresponds to a height of approximately 15 mm. Afterwards, the cells were 
washed at least four times with 200 µL of PBS in each port, again perfused from both sides of the 
chip (that is, the washing solution was perfused from each side at least twice). Then, ER-alpha 
antibody (HC-20, Santa Cruz Biotech) was diluted 1:200 in 10 mg/mL BSA with 0.3 % (v/v) 
Triton-X PBS. At least 100 µL was applied to each port at 4 ° C for at least 12 h. Again, perfusion 
was done from both sides of the chip, for a total staining time of at least 24 h. Then, the cells on 
the chip were thoroughly washed as described. Then, secondary goat anti-rabbit antibody (IgG-
CFL 647, abcam) was diluted 1:200 in 10 mg/mL BSA with 0.3 % (v/v) Triton-X PBS. About 100 
µL of this diluted antibody solution was applied to each port for at least 4 h at room temperature. 
After washing again with the previously described procedure, at least 200 µL of Hoechst stain 
(concentration: ~100 ng/mL) was added to each port for at least 12 h. To improve image quality, 
an 80 % (v/v) glycerol solution in PBS with trace amounts of ascorbic acid was added to the chip 
immediately before imaging.   
Images were captured with a confocal microscope (Zeiss LSM 700, objective: Plan-
Apochromat 40x/1.3 Oil DIC M27). To detect the signal for ER-α, laser power at 639 nm was set 
to 60 %, gain was set to 450, and pinhole size was set to about 1 Airy unit. These parameters 
were kept constant throughout. To detect the signal for the Hoechst nuclear stain, laser power at 
405 nm, gain, and pinhole size were adjusted as needed. Approximately 10 images were captured 
at two different digital zooms (0.7 or 1.3). Contrast and brightness were evenly adjusted across 
all images as needed. No non-linear corrections were applied. For clarity, the 639 nm channel 
was converted to green on the software (Zen 2 Blue edition) before further use.  
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2.5.7 Image analysis of ER-α expression levels 
All confocal images were analyzed in ImageJ software (NIH). First, the red, green, and blue 
channels were separated. Then, the channels were converted to greyscale images, and placed in a 
stack. The mean gray value of the green channel that co-localized with a positive signal in the 
blue channel (the Hoechst stain) was then quantified. In this manner, only ER-α which localized 
in the nuclear region was quantified. At least 20 nuclei were imaged per condition, analyzed 
across no fewer than three images.  
 
2.5.8 Immunostaining for integrin β1 
To stain for integrin β1, cells grown in the microfluidic chips for 6 days were fixed in 
methanol-free 3.7 % paraformaldehyde for at least 6 h at room temperature. Then, cells were 
blocked with a PBS solution containing 10 mg/mL bovine serum albuminum (BSA), 10 % (v/v) 
fetal bovine serum (FBS), and 0.1 % (v/v) triton-X (Fisher) for at least 9 h. The blocking solution 
was perfused from both sides of the chip, with at least 100 µL of solution used in each port. 
Afterwards, the cells were washed at least four times with 100 µL of PBS in each port, again 
perfused from both sides of the chip. Then, anti-β1 integrin mouse antibody (P5D2, abcam) was 
diluted 1:100 in 10 mg/mL BSA with 0.1 % (v/v) triton-X in PBS. At least 100 µL of the diluted 
antibody solution was applied to each port at 4 ° C for at least 12 h. Perfusion was done from 
both sides of the chip. Then, the cells on the chip were thoroughly washed as described 
previously. Afterwards, secondary goat polyclonal to mouse antibody with Cy5 (ab6563, abcam) 
was diluted 1:200 in 10 mg/mL BSA with 0.1 % (v/v) Triton-X PBS. About 100 µL of this 
diluted antibody solution was applied to each port for at least 4 h at room temperature. Lastly, an 
80 % (v/v) glycerol solution (Fisher) in PBS with trace amounts of ascorbic acid was added to 
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the chip immediately before imaging. All images were captured within two weeks from the end 
of staining. When not imaging, samples were stored at 4 ˚ C in the dark. 
Images were captured with a confocal microscope (Zeiss LSM 700, objective: Plan-
Apochromat 40x/1.3 Oil DIC M27). To detect the signal for integrin β1, laser power at 639 nm 
was set to 55 %, detector gain was set to 575, and pinhole size was set to about 1 Airy unit. 
These parameters were kept constant throughout. Contrast and brightness were evenly adjusted 
across all images as needed. No non-linear corrections were applied.  The 639 nm channel was 
converted to red or orange in the Zen Blue software before further use.  
 
2.5.9 Immunostaining for E-cadherin  
To stain for E-cadherin, cells grown in the microfluidic chips for 6 days were fixed in 
methanol-free 3.7 % paraformaldehyde for at least 6 h at room temperature. Then, cells were 
blocked with a PBS solution containing 10 mg/mL bovine serum albuminum (BSA), 10 % (v/v) 
fetal bovine serum (FBS), and 0.1 % (v/v) triton-X for at least 9 h. The blocking solution was 
perfused from both sides of the chip, with at least 100 µL of solution used in each port. 
Afterwards, the cells were washed at room temperature at least four times with 100 µL of PBS in 
each port, again perfused from both sides of the chip. Then, anti-E-cadherin primary rabbit 
antibody (24E10, Cell Signaling Technology) was diluted 1:100 in 10 mg/mL BSA with 0.1 % 
(v/v) Triton-X in PBS. At least 100 µL of the diluted antibody solution was applied to each port 
at 4 ° C for at least 12 h. Perfusion was done from both sides of the chip. Then, the cells on the 
chip were thoroughly washed as described previously. Afterwards, secondary anti-rabbit 
antibody with an Alexa Fluor conjugate (Cell Signaling Technology) was diluted 1:100 in 10 
mg/mL BSA with 0.1 % (v/v) Triton-X in PBS. About 100 µL of this diluted antibody solution 
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was applied to each port for at least 4 h at room temperature. After thorough washing, an 80 % 
glycerol solution in PBS with trace amounts of ascorbic acid was added to the chip immediately 
before imaging.  
Images were captured with a confocal microscope (Zeiss LSM 700, objective: Plan-
Apochromat 40x/1.3 Oil DIC M27). To detect the signal for E-cadherin, laser power at 555 nm 
was set to 18 %, detector gain was set to 575, and pinhole size was set to about 1 Airy unit. 
These parameters were kept constant throughout. At least 10 images were captured, each with a 
different digital zoom (0.7 and 1.3). Contrast and brightness were evenly adjusted across all 
images as needed. No non-linear corrections (e.g., gamma corrections) were applied. For clarity, 
the 555 nm channel was converted to green in the Zen Blue software before further use.  
 
2.5.10 Image analysis for integrin β1and E-cadherin  
To quantify the expression level for integrin β1and E-cadherin, the images were split into 
individual channels in ImageJ (red, green, and blue). Here, each channel is converted into a 
separate grey and white image. Then, the mean gray value was calculated for a given region of 
interest. The mean gray value reports the pixel intensity averaged over a region of interest; a 
higher mean gray value corresponds to a higher level of expression. For integrin β1, a cell 
spheroid as well as its extracellular components was considered as a region of interest. For E-
cadherin, only the cell spheroid was considered as the region of interest. At least ten spheroids 
were measured per condition, taken from no fewer than 5 images. For accurate reporting of the 
expression level, the background mean gray value was measured and subtracted from the mean 
gray value for a region of interest. 
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2.5.11 Statistical analysis of data  
To quantify statistical significance between two or more conditions, a one-way ANOVA test 
with a post-hoc Tukey’s test (R Studio 3.2.2) was used. p values lower than 0.05 were considered 
statistically significant.  
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2.6 Figures and Tables 
 Amount (µL) 
Collagen-PEG Mass 
Ratio 
0 0.25 0.5 
10X PBS 100.00 100.00 100.00 
Sterile 1.0 N NaOH 16.47 16.47 16.47 
0.1 M Hepes 30.00 30.00 30.00 
P/S 1.00 1.00 1.00 
L- Glutamine 10.00 10.00 10.00 
FBS 60.00 60.00 60.00 
PEG solution (300 
mg/mL, MW 7,500 g/mol) 
0.00 5.00 10.00 
Sterile dH2O 66.54 61.54 56.54 
Rat Tail Collagen 715.99 715.99 715.99 
 
Table 2.1 Example recipe for forming collagen-PEG gels.  
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Figure 2.1 Stiffness of collagen gels mixed with controlled amounts of polyethylene glycol (PEG) 
(MPEG/Col). (a) Schematic depicting the formation of a collagen hydrogel. A dissolved acidic 
collagen solution is mixed with DMEM components (fetal bovine serum, glutamine, and 
penicillin-streptomycin). NaOH and HEPES are then added to increase the pH of the solution, in 
turn making a gel at 37 ˚ C. The pH change was the same for all gel formulations. (b) Storage 
modulus values for the pure collagen gel with no PEG (MPEG/Col = 0), the collagen gel with MPEG/Col 
of 0.25, and the collagen gel with a mass ratio of PEG to collagen of 0.5 with MPEG/Col of 0.5. 
Storage modulus was measured at a frequency of 1 Hz. * represents the statistically significant 
difference of values between conditions (p < 0.05). Values and error bars on the graphs represent 
mean and standard deviation of at least three samples per condition, respectively.  
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Figure 2.2 Microstructure of collagen gels mixed with controlled amounts of polyethylene glycol 
(PEG). (a) Scanning electron microscopy (SEM) images of collagen gels with controlled MPEG/Col. 
Scale bars correspond to 10 µm (low magnification, left column) or 1 µm (high magnification, 
right column). (b) Fiber diameter of the resulting collagen fibers, as determined from SEM images 
of the gels. (c) Pore area of the fibrous collagen network as determined from SEM images of the 
gels. No statistical significance is denoted between the different conditions in (b) or (c).  
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Figure 2.3 Hydraulic conductivity analysis for collagen gels made with controlled amounts of 
polyethylene glycol (PEG) to collagen mass ratio (MPEG/Col). (a) Image of the dynamic mechanical 
analyzer (DMA) setup loaded with a collagen gel. (b) Schematic describing the process of loading 
and testing the collagen gel in the DMA. The collagen gel was immersed in phosphate buffer saline 
(PBS). Compressive force by the DMA (FDMA) is balanced by the reaction force by the collagen 
gel (Fsample) and the surface tension of phosphate buffered saline (FPBS). (c) Hydraulic conductivity 
data for the pure collagen gel with no PEG (MPEG/Col = 0), the collagen gel with MPEG/Col of 0.25, 
and the collagen gel with MPEG/Col of 0.5. Values represent the mean of at least three samples per 
condition. Error bars represent standard deviation. No statistical significance is denoted between 
the different conditions in (c). 
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Figure 2.4 Preparation of Cell-Microenvironment-on-a-Chip (CMOC) system. (a) Schematic 
describing preparation of a cell-microenvironment-on-a-chip (CMOC) system. (i) A PDMS chip 
is prepared via standard lithography, and then bonded to a glass slide. (ii) A pregel collagen 
solution containing cells is loaded into a syringe, then pumped through the CMOC system. (iii) 
After collagen gel formation, a pressure gradient is applied across the CMOC, in turn inducing an 
interstitial flow. (b) Brightfield microscope image of CMOC loaded with a collagen (MPEG/Col= 0) 
or collagen-PEG gel (MPEG/Col= 0.5). The red arrow depicts the approximate path of perfusion 
through the gel system. White scale bar corresponds to 100 µm. 
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Figure 2.5 Cell proliferation analysis (a) Brightfield image of breast cancer cells grown in the 
CMOC system after six days. Cells were cultured in the gels for 6 days, both without perfusion (-
Perf) and with perfusion (+Perf). White scale bar corresponds to 100 µm. (b) The normalized 
cross-sectional area of spheroids as quantified with brightfield images over 6 days of cell culture. 
At least 4 areas were quantified for each time point. * represents the statistically significant 
difference of values between conditions (p < 0.05). Values and error bars on the graphs represent 
mean and standard deviation of at least three samples per condition, respectively 
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Figure 2.6 Immunostained image analysis of MCF-7 breast cancer cells cultured in the CMOC 
system. (a-i) Confocal microscope images of cells stained for ER-α. The green stain corresponds 
to ER-α, and the blue stain corresponds to the Hoechst nuclear stain. (a-ii) Expression levels of 
ER-αas quantified with ImageJ. (b-i) Confocal microscope images of MCF-7 breast cancer cells 
stained for integrin β1 (orange). (b-ii) Expression levels of integrin β1 as quantified with ImageJ. 
(c-i) Confocal microscope images of cells stained for E-cadherin (red). (c-ii) Expression levels of 
E-cadherin quantified with ImageJ. All scale bars correspond to 50 µm. Cells were grown without 
perfusion (-Perf) and with perfusion (+Perf) in the gels with storage modulus of 0.2 and 1.0 kPa. 
Values and error bars on the graphs represent mean and standard deviation of at least five images 
per condition. * denotes a condition that is statistically significant (p < 0.05) when compared to 
the value at 0.2 kPa in the absence of perfusion (-Perf). 
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Figure 2.7 Schematic depicting the effect of PEG on the collagen microstructure. (a) The collagen 
triple helix is stabilized by hydrogen bonding networks between peptide groups on adjacent chains. 
(b) The addition of PEG disrupts the hydrogen bonding networks that hold collagen together, in 
turn weakening the gel structure.  
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CHAPTER 3: 3D PRINTING ENABLES SEPARATION OF 
ORTHOGONAL FUNCTIONS WITHIN A HYDROGEL PARTICLE2 
 
3.1 Introduction  
 In recent years, an increasing number of multifunctional particle formulations have been 
developed for a variety of applications, ranging from consumer products to drug delivery 
devices.1 Incorporating multiple functionalities into a single particle significantly reduces the 
total number of particles needed for any given application, as in the case of theranostic (dual 
therapeutic and diagnostic) nano- and micro-particles.2 Moreover, spatial separation of dual 
functionalities in a single particle may enable a synergistic physical or chemical property that 
cannot be replicated by two single-functional particles in the same dispersion.3 This motivates 
                                                     
2 This work has been previously published in Biomedical Microdevices. The final publication is 
available at http://link.springer.com/article/10.1007/s10544-016-0068-9. I would like to 
acknowledge my collaborators on this project, including Dr. Molly Melhem, Ellen Qin, and Dr. 
Rashid Bashir. Special thanks are given to Ritu Raman for her help with figure preparation, as 
well as her expertise in 3D printing. I would also like to thank Sanjeet Sen, my undergraduate 
researcher for almost two years. I acknowledge Boris Odintsov for his assistance in MR imaging. 
This work was funded by the National Science Foundation (NSF) Science and Technology 
Center EBICS (Grant CBET-0939511) and National Institute of Health (1R01 HL109192 to 
H.K). R.R was funded by an NSF Graduate Research Fellowship (Grant DGE-1144245) and 
NSF CMMB IGERT at UIUC (Grant 0965918). N.C. was funded by a Dow Graduate 
Fellowship. 
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developing a fabrication methodology for assembly of multiphasic particles, in which different 
functional modalities are spatially separated to avoid interference between them. A series of 
fabrication strategies have been proposed to prepare multiphasic particles, such as electrojetting, 
emulsification, and standard lithography techniques.4–6 Despite impressive results reported to 
date, concerns still remain regarding the customizability of these techniques.  
 A wide variety of 3D printing technologies and printable biomaterials have been 
developed to suit the needs of biomedical applications.7,8 Of these materials, highly absorbent 
hydrogels have been of particular interest to the biomedical community due to their tuneable 
stiffness and permeability. Hydrogels can be functionalized with various bioactive moieties by 
chemical modification of gel-forming polymers.9,10 Taking advantage of the rapid development 
of this field, this study demonstrates a 3D printing-based strategy to manufacture biphasic 
hydrogel particles with spatially distributed functional moieties. Specifically, a 
stereolithographic apparatus (SLA) was used to fabricate hydrogel particles with distinct 
functional compartments. Using this fabrication technology, we examined whether controlling 
laser irradiation speed, which in turn allows for tuning of the energy dose delivered to pre-gel 
solutions, could be used to predict and control the cross-linking kinetics of the radical 
polymerization reaction. By doing so, we were able to customize and control the shape, size, and 
aspect ratio of the layers of the gel particles with great precision. We tested boundary stability 
across different layers using brightfield and confocal microscopy, and used these results to 
incorporate two moieties, bovine serum albumin (BSA) and superparamagnetic iron oxide 
nanoparticles (SPIONs), into biphasic gel particles. The release kinetics of BSA and magnetic 
resonance imaging (MRI) contrast of particles were evaluated to test the effect of spatially 
segregating orthogonal functions within a particle. The results of this study demonstrate an 
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expedited approach for assembling multifunctional bioactive gel particles for a diverse array of 
biomedical applications including image-based targeted drug delivery. 
 
3.2 Results and Discussion 
3.2.1 3D printing of hydrogel particle arrays 
A commercial SLA was modified for printing photosensitive hydrogel polymers as 
previously demonstrated and shown in Figure 1a.11 Liquid pre-gel solution, composed of poly 
(ethylene glycol) diacrylate (PEGDA) and a biocompatible photo-initiator, was injected onto the 
motorized stage and selectively cured by the SLA’s ultraviolet laser. Following fabrication of 
each layer, the motorized stage moved down by a prescribed amount, and a new layer of pre-gel 
solution was manually injected and subsequently polymerized.  
To enable high-throughput fabrication of many gel particles, the computer-controlled laser 
traced a 2D cross-section of the 3D hydrogels prescribed by a computer aided design (CAD) file, 
shown in Figure 1b. This file contained a 30 x 30 array of cylinders of specified diameter and 
spacing. Due to the swelling properties of the hydrogels used in this study, these CAD-prescribed 
dimensions were not preserved in the final fabricated part. Figure 1b shows that an array of 
PEGDA 700 g/mol cylinders 200 μm in diameter spaced 200 μm apart becomes, after immersion 
and swelling in a solution of phosphate buffered saline (PBS) for an hour, an array of cylinders 
270 μm in diameter spaced 130 μm apart. This trend was preserved for gel cylinders of larger 
diameters, as demonstrated in Figures 1c-d and Figure 3a, with gel arrays demonstrating an 
average swelling ratio of 140%. This result is consistent with results previously demonstrated for 
polymerization of PEGDA hydrogels.12,13  
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The ultraviolet illumination energy dose required to cure photosensitive polymer solutions 
has been previously characterized by the cure-depth equation,14,15 an adapted form of the Beer-
Lambert equation which relates the intensity of a light source to the exponential decay of its 
intensity in an absorbing medium. The SLA regulates ultraviolet light intensity by keeping the 
laser power constant (23 mW/cm2) and adjusting laser scan speed to regulate the energy density 
delivered (ranging from 108-266 mJ/cm2 in this study). 
The effect of ultraviolet light density on pre-gel solutions of PEGDA (400 g/mol and 700 
g/mol) was tested, revealing that the degree of cross-linking was directly dependent on the 
energy dose delivered to the PEGDA, as shown in Figure 3.2a. The thickness of the gels was 
likewise regulated by tuning the energy dose, as shown in Figure 3.2b and Figure 3.3b. Gel 
thickness was also shown to be dependent on the concentration of PEGDA in the pre-gel solution 
(20% and 30% PEGDA 700 g/mol), with increasing concentration correlated with increasing 
thickness, as demonstrated in Figure 3.2c.  
 
3.2.2 Fabrication of multi-layered hydrogel particles 
The ability of the SLA to precisely tune the diameter, thickness, and spacing of gel arrays 
provided a highly reproducible methodology with which to fabricate multi-layered gel particles. 
The dimensions and properties of each layer could be tuned by regulating the composition of the 
pre-gel solution used in each layer. For instance, solutions of PEGDA 700 g/mol prepared with 
different fluorescent dyes (i.e., red-colored rhodamine and green-colored fluorescein) were used 
to study the spatial separation and boundary stability of multi-layer gel particles via confocal 
imaging. Specifically, a confocal microscope was used to measure the fluorescence intensity 
(represented by gray value) emitted by the gels in response to illumination at two different 
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excitation wavelengths. Plots of measured mean gray value as a function of position along the 
thickness of two-layer, three- layer, and four-layer gels are shown in Figure 4 for 20% and 30% 
PEGDA. While the thickness of each layer is dependent on the polymer composition, a defined 
interface between layers can be created in both cases, as long as the polymer concentration is the 
same across layers. This boundary stability suggests that this high-throughput 3D printing 
approach can be used to spatio-selectively distribute different properties within a single gel 
particle. 
 
3.2.3 Spatial compartmentalization of functional epitopes in multi-layered hydrogel particles 
Coupling the SLA fabrication approach with a chemical conjugation technique enabled the 
spatioselective localization of biomolecules within specific layers of the gels. One layer of the 
gel particle was modified by introducing alginate methacrylate (AM), which can cross-link with 
PEGDA, into the pre-gel solution as shown in Figure 5a. Incorporation of fluorescent protein A, 
1-ethyl-3-carbodiimide (EDC), and n-hydroxysuccinimide (NHS) into the fabricated gel 
containing PEGDA and AM resulted in protein A molecules chemically conjugated to AM 
molecules via a carbodiimide-induced chemical reaction. A stability test conducted using 
rhodamine-tagged protein A shows one compartment of the gel selectively conjugated with 
protein A (Figure 3.5b). Protein A has been previously used to immobilize a variety of antibodies 
on different nanoparticle surfaces.16 Therefore, this chemistry and processing technique will be 
broadly applicable to the spatioselective biochemical modification of multi-layered gels. 
To highlight the importance of spatially organizing different functional moieties in these 
gels, each layer of the two-layer gel particle was functionalized with superparamagnetic iron 
oxide nanoparticles (SPIONs) and bovine serum albumin (BSA), respectively, as shown in 
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Figure 3.6a. SPIONs are widely used as a magnetic resonance (MR) imaging contrast agent.17,18 
By separating SPIONs from BSA, a model large molecule drug, we aimed to minimize 
interferential effects between SPIONs and BSA. The SPIONs would generate larger contrast in 
MR images, while BSA molecules would be released at controlled rates. 
As shown in Figure 3.6b, MR images of an agarose gel loaded with bi-layered gel particles 
demonstrated that particles loading BSA and SPIONs within different gel layers created a larger 
contrast than those in which BSA and SPIONs are encapsulated in the same layer. Using ImageJ, 
the average pixel intensity (mean gray value) was quantified for each image captured with a 
spin-echo sequence. At a given echo time, an image with more contrast correlates with a darker 
image and a lower mean gray value.  The gray value for gels with BSA and SPIONs in separate 
compartments indicated the highest degree of contrast, demonstrating the advantage of 
segregation of functional moieties within a gel.  
Furthermore, measurements of the cumulative fraction of BSA released, shown in Figure 
3.6c, demonstrate that a significantly larger amount of BSA was released from the gels in which 
BSA and SPIONs were loaded in separated layers. The gels in which SPIONs and BSA were 
encapsulated in the same layer released only 50% of loaded BSAs over 4 days, thus implicating 
the presence of uncontrolled attraction between SPIONs and BSA in the gels. By contrast, the 
gels with spatial segregation between SPIONs and BSA released 80% of BSA molecules within 
48 hours. As determined from the Peppas-Ritger equation (Equation 3.1),19 the gels with BSA 
and SPIONs in separate layers had a 1.9-fold larger release rate constant (k) than the gels with 
BSA and SPIONs in the same gel layer. Spatial segregation thus circumvented undesirable 
interactions between nanoparticles and proteins in the biphasic configuration. 
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To elucidate the mechanism by which hydrogel properties influence the molecular release and 
SPION encapsulation properties of the “separated” and “co-encapsulated” particles, control 
experiments were conducted with millimeter-sized PEGDA discs containing BSA (termed 
“+BSA/-SPIONs”), SPIONs and BSA (+BSA/+SPIONs), or no additional components (-BSA/-
SPIONs). The BSA and SPION-containing hydrogels had the same swelling ratio values as the 
pure PEGDA hydrogel. Thus, the presence of BSA or SPIONs had no significant effect on the 
swelling properties of the hydrogel. In addition, the mesh size, as calculated from established 
thermodynamic relationships for hydrogel networks, was the same for all formulations at 
approximately 2.4 nm (Table 3.1).20 This mesh size is near the hydrodynamic radius of BSA (~ 3 
nm),21 but much smaller than the SPION size (10 nm, per manufacturer). Therefore, BSA will 
diffuse through the hydrogel network, but SPIONs will remain entrapped within the gel. 
To probe the potential interactions between SPIONs and BSA, a separate set of pregel solutions 
were once again prepared, and SPIONs were removed from the polymer solution and then analyzed 
for changes in zeta potential. In this manner, we can infer if the components in the pregel solutions 
will bind to the iron oxide surface. It is clear that both PEGDA and BSA nonspecifically bind to 
the iron oxide surface, based on the significant reduction in zeta potential for both conditions 
(Figure 3.7). Therefore, the presence of SPIONs in the “co-encapsulated” particle configuration 
likely interferes with the release of BSA from hydrogel, as BSA will nonspecifically bind to 
SPIONs during the diffusion process through the hydrogel matrix. In addition, the presence of 
BSA and PEGDA significantly reduces the surface charge of the SPIONs, in turn reducing the 
colloidal stability of the SPIONs. With a reduced stability, it is possible that the relaxivity of the 
SPIONs may be reduced in turn.22 The binding of BSA to the SPION surface demonstrates why 
the “co-encapsulated” configuration displayed a lower molecular release as well as a lower MR 
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contrast when compared to the “separated” particle configuration. Additional studies can be 
conducted to elucidate the kinetics of BSA and PEGDA binding to SPIONs.  
 
3.3 Conclusion  
This study demonstrates a customizable fabrication methodology for creating biphasic gel 
particle arrays. Stereolithographic fabrication allows for precise tuning of the gel array shape, 
size, and cross-linking density by providing mechanisms for precise regulation of polymerization 
kinetics. The properties of gels can be readily tuned to suit different applications through spatial 
segregation of bioactive moieties within different compartments. In future studies, multi-layered 
multi-functional gel constructs can be targeted at a wide variety of biomedical applications 
including medical diagnosis and therapeutics. 
 
3.4 Materials and Methods  
3.4.1 Pre-gel solution production 
Poly (ethylene glycol) diacrylate (PEGDA) with molecular weights of 400 and 700 g/mol 
(Sigma-Aldrich) were dissolved in phosphate buffered saline (PBS, Corning CellGro) at 
concentrations of either 200, 250, or 300 mg/mL. Separately, 1-[4-(2-hydroxyethoxy) phenyl]-2-
hydroxy-2-methyl-1-propanone-1-one photoinitiator (Irgacure 2959, Ciba Chemicals) was 
dissolved in dimethyl sulfoxide (DMSO, Fisher Scientific), and mixed with the PEGDA solution 
to reach a final concentration of 1-5 mg/mL  Irgacure 2959. Alginate methacrylate 
(AM)/PEGDA pre-gel solution, a mass of PEGDA was weighed, dissolved in the presence of 5 
mg/mL AM in PBS, and degassed under vacuum in the dark for at least 12 h. AM was prepared 
by conjugating 2-aminoethylmethacrylate to the carboxylic acids of alginate (FMC) via 
carbodiimide chemistry, as previously reported 23. Bovine serum albumin (BSA, Sigma-Aldrich) 
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was functionalized with either fluorescein-isothiocyanate or rhodamine B-isothiocyanate to form 
BSA-FITC or BSA-RBITC, respectively, according to the manufacturer’s protocol.   
 
3.4.2 Stereolithographic 3D printing 
CAD software (SolidWorks, Dassault Systems) was used to fabricate arrays of particles of 
varied dimensions and spacing. These were manufactured using a laser-based stereolithographic 
apparatus (SLA 250/50, 3D Systems). As the laser (325 nm) rasterized across the surface of the 
pre-gel solution in the pattern prescribed by the CAD file, it was cross-linked or “cured” in 
regions that were exposed to ultraviolet light. Following fabrication of each layer of the array, 
the motorized SLA stage moved down by a prescribed amount and the rasterizing process was 
repeated. Once the multi-layer array was complete, the particles were washed and stored in PBS 
and kept in the dark at 4°C until imaging. 
 
3.4.3 Confocal imaging of particles 
After fabrication, particles were gently detached from the glass slide using a plastic pipette 
tip, placed in a dish, and imaged using a confocal microscope (Zeiss LSM 700, objectives: 
10x/0.3 or 20X/0.8). The excitation wavelength was either 488 nm (for BSA-FITC) or 555 nm 
(for BSA-RBITC). As needed, brightfield images were captured in parallel with fluorescent 
images. If you are reading this, wear an orange shirt to my defense. All image analysis was done 
with ImageJ software (NIH) or Zen 2 Lite (Zeiss). 
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3.4.4 Modification of particles with fluorescent Staphylococcus Aureus (SpA) protein A  
SpA was modified with RBITC, as previously described.16.Particles were incubated in 
7mg/mL of 1-ethyl-3-carbodiimide (EDC) and 10 mg/mL of n- hydroxysuccinimide (NHS) for 
30 min. The particles were then washed, and a small volume of 2-mercaptoethanol was added. 
They were then incubated in SpA-RBITC (protein A) for 15 min, washed 5 times, and imaged. 
 
3.4.5 Magnetic resonance imaging of particles  
Particles were fabricated with PEGDA containing superparamagnetic iron oxide 
nanoparticles (SPIONs, SHP-10-10; Ocean NanoTech) and BSA-RBITC. BSA-RBITC and 
SPION concentration were constant at 1 mg/mL and 100 µg Fe/mL, respectively. After 
fabrication, particles were dispersed in PBS, then rapidly mixed with warm 10 mg/mL agarose 
solution in a borosilicate tube and gelled at room temperature. Agarose gel with no particles was 
prepared as a control. MR images were captured with a spin-echo sequence on a Varian 600 
MHz Small-Bore Scanner.  
 
3.4.6 Quantification of BSA release  
After fabrication, particles were released, mixed in PBS, then incubated at 37 ˚C and shaken 
at 100 rpm (Heidolph Rotamax 120). At each time-point, the particles were centrifuged at 100 
rcf for 3 min (Eppendorf centrifuge 5424). The fluorescent intensity of the supernatant was then 
measured (Tecan Infinite 200 PRO). The total theoretical amount of BSA-RBITC encapsulated 
was estimated by considering the volume of a rod-shaped particle with a diameter of 250 µm and 
a height of 250 µm loaded with 1 mg/mL of BSA. BSA release rate was quantified according to 
the Peppas-Ritger equation: 
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 𝑀𝑡/𝑀∞ = (𝑘)(𝑡
𝑛)          (3.1) 
where Mt is the mass released at time t, M∞ corresponds to the mass released at time infinity 
(total amount encapsulated), and k and n correspond to the release constant and the diffusional 
exponent, respectively. 
 
3.4.7 Calculation of swelling ratio of control hydrogels  
The swelling ratio of the control hydrogels was calculated as: 
𝑄 = 𝑣2,𝑠
−1 = 𝜌𝑝 (
𝑄𝑚
𝜌𝑠
+
1
𝜌𝑝
)         (3.2) 
Whereby Q is the degree of swelling, v2 is the volume fraction of polymer in a swollen hydrogel, 
𝜌p is the density of PEGDA (1.28 g/cm3), 𝜌S is the density of water (1 g/cm3), and Qm is the mass 
ratio of swelled gel to dried gel.  
 
3.4.8 Calculation of molecular weight between crosslinks 
The molecular weight between crosslinks (Mc) was calculated using the modified Merrill-
Peppas equation24: 
1
𝑀𝑐
=
2
𝑀𝑁
−
𝜈
𝑉1(𝑙𝑛(1−𝑣2,𝑠)+𝑣2,𝑠+𝜒1𝑣2,𝑠
2 )⁄
𝑣2,𝑟(
𝑣2,𝑠
𝑣2,𝑟
)
1/3
−
𝑣2,𝑠
2𝑣2,𝑟
        (3.3) 
Whereby Mn is the molecular weight of the pregel polymer chains (700 g/mol), ν is the specific 
volume of PEGDA (0.89 cm3/g), V1 is the molar volume of water (18 cm
3/mol), v2,s is the 
swollen volume fraction of polymer, v2,r is the relaxed volume fraction of polymer (0.25), and χ1 
is the Flory-Huggins interaction parameter (0.43).  
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3.4.9 Calculation of mesh size  
The root mean end-to-end distance of PEGDA was first calculated using: 
𝑟𝑜
2 = 𝑙2 [2
𝑀𝑐
𝑀𝑟
] 𝐶𝑛         (3.4) 
Whereby l is the carbon-carbon bond distance (0.154 nm), Cn is the characteristic ratio of 
PEGDA (4), and Mr is the molecular weight of the PEGDA repeating units (44 g/mol). 
 
The mesh size for the control hydrogels was defined as25: 
𝜉 = (𝑟𝑜
2)0.5(𝑣2,𝑠)
−
1
3         (3.5) 
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3.5 Figures and Tables 
 
Figure 3.1 Hydrogel array fabrication schematic. (a) Schematic of stereolithographic 3D printers 
used to fabricate hydrogel particles. (b) Comparison of hydrogel particle diameter and spacing 
specified in CAD file (top view, zoom inset of digital rendering) and fabricated part (top view, 
zoom inset of brightfield image). (c) Quantitative comparison of PEGDA 700 g/mol hydrogel 
particle specified and fabricated part diameter reveals a swelling ratio of 140%. (d) Quantitative 
comparison of PEGDA 700 g/mol hydrogel particle spacing. 
 
49 
 
 
Figure 3.2 Multi-material 3D fabrication. (a) Regulation of ultraviolet energy dose provides a 
mechanism of control over polymerization kinetics and cross-linking density, with the degree of 
crosslinking mediated by the composition of the polymer. Scale bars correspond to 500 μm. (b) 
Thickness of hydrogel particles can also be regulated by tuning the ultraviolet energy dose, with 
higher energy doses corresponding to larger thicknesses (note that x- axes do not start from zero 
values). (c) Varying the concentration of PEGDA in the pre-gel solution provides an additional 
mechanisms of control over particle thickness. 
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Figure 3.3 Changing the aspect ratio of printed microgels. (a) Example of a 30% PEGDA 700 
g/mol disc-shaped hydrogel particle formed by changing the CAD file sent to the 
stereolithographic 3D printer, showing the versatility and customizability of this rapid fabrication 
approach. Scale bar corresponds to 500 µm. (b) Example of a 30% PEGDA 400 g/mol 
“matchstick” hydrogel particle formed by varying the energy dose applied for each layer during 
fabrication, resulting in significantly different thicknesses in each of the two layers. Scale bar 
corresponds to 500 µm. 
 
 
 
 
 
 
 
 
51 
 
 
Figure 3.4 Boundary stability characterization of multi-layer hydrogel particles. (a-c) Confocal 
images (i) and plots of light intensity/gray value as a function of position along the thickness of a 
microgel (ii) for two-layer (a), three layer (b), and four-layer (c) hydrogel particles fabricated 
using 20% PEGDA 700 g/mol tagged with red or green fluorophore. Scale bars correspond to 
500 μm. (d-f) Confocal images (i) and plots of light intensity/gray value as a function of position 
along the thickness of a microgel (ii) for two-layer (d), three layer (e), and four-layer (f) hydrogel 
particles fabricated using 30% PEGDA 700 g/mol tagged with red or green fluorophore. Scale 
bars correspond to 500 μm. 
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Figure 3.5 Spatioselective functionalization of hydrogel particles. (a) Schematic of chemical 
composition of pre-gel solutions in each layer of a two-layer particle. One layer contains pure 
PEGDA, the other layer is a mixed solution of PEGDA and methacrylated alginate, allowing for 
the fabrication of a cross-linked 3D matrix of inter-locked PEGDA and alginate monomers 
following UV-initiated cross-linking (i). Spatial segregation of alginate in one layer of a two-
layer particle allows for spatially selective localization of fluorophore-tagged proteins (ii). (b) 
Spatial segregation of fluorophore-tagged protein as visualized using fluorescence imaging. 
Scale bar corresponds to 200 µm. 
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Figure 3.6 (a) Schematic depicting particles loaded into an agarose gel in a glass tube for MR 
imaging. (1) depicts the microgel with BSA-RBITC and SPIONs segregated, (2) depicts the 
microgel with BSA-RBITC and SPIONs co-encapsulated, and (3) depicts a blank agarose gel as 
a control. (b) The resulting MR images (i) of (1), (2), and (3). Scale bar corresponds to 6 mm. 
Gray values show greater contrast in particles with phase separation (ii). (c) Cumulative fraction 
of encapsulated BSA released as a function of time for the separate and combined cases (i) 
demonstrating the enhanced release kinetics observed in biphasic particles (ii).  
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Table 3.1 Mesh size and average molecular weight between two adjacent crosslinks for bulk 
PEGDA hydrogels fabricated with or without BSA or SPIONs.  
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Figure 3.7 Zeta potential for SPIONs co-incubated with BSA, and BSA and PEGDA. SPIONs in 
PBS are used as a control.  
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CHAPTER 4: CHEMICAL AND MECHANICAL MODULATION OF 
POLYMERIC MICELLE AND VESICLE ASSEMBLY3 
 
  
4.1 Introduction 
In the past 50 years, nano-sized micelles and vesicles have been studied as carriers of various 
molecules for cosmetic, medical, and agricultural products.1–4 These nanocarriers are noted for 
their structural stability, and can help retain the activity of multifactorial compounds.5 Polymers 
can be chemically modified to tailor degradation rate and mechanism (e.g., enzymatic digestion, 
optical trigger) and subsequent molecular release rate.6,7 In addition, the nanoparticle surface can 
be chemically or physically engineered to present a desired number and type of molecules for the 
targeted delivery of molecular cargos.8,9   
                                                     
3 I would like to thank my collaborators for their microfluidic expertise and COMSOL help, most 
notably Joseph Whittenberg, Vivek Kumar, Jeremy Schieferstein, and Prof. Paul Kenis. I would 
like to thank my Kong lab collaborators, including Jinrong Chen and Prof. Jae Hyun Jeong, for 
their invaluable help in chemical synthesis. I would also like to thank my Soongsil collaborators, 
including Prof. Il Won Kim and Insil Choi. I would also like to acknowledge the School of 
Chemical Sciences (SCS) graphics office for their assistance with figures. Special thanks are also 
due to Wacek Swiech and the staff at the Frederick Seitz Materials Research Laboratory for help 
with transmission electron microscopy (TEM). Work was funded by the National Institutes of 
Health (1R01 HL109192 to H.J.K). N.C. was supported by a Dow Graduate Fellowship. 
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Polymeric micelles and vesicles are typically formed by the self-assembly of amphiphilic 
polymers during a solvent exchange process where amphiphilic polymers are first dissolved in an 
organic solvent and subsequently introduced into an aqueous phase.10–12 These polymers are 
typically synthesized by connecting a series of water-soluble polymers such as poly(ethylene 
glycol),13 hyaluronic acid,14 poly(2-hydroxyethyl methacrylate),15 or polypeptides16 with 
hydrophobic segments to create an amphiphilic block copolymer or graft copolymer. In aqueous 
media, amphiphilic polymers associate to form particles in a form of micelle or vesicle, depending 
on the ratio of hydrophobic and hydrophilic domains in the polymer. 17,18 
Recently, microfluidic chips have been considered for various nanofabrication strategies, as 
these devices can mix small volumes (~nL-μL) of aqueous and organic phases at controlled 
rates.19–21 Microfluidic systems have been utilized previously to produce highly monodisperse 
populations of liposomes,22 quantum dots,23 and emulsions.24 In particular, microfluidic platforms 
that rapidly mix solutions via hydrodynamic flow focusing, where a central organic solvent-
polymer stream is sheathed by adjacent aqueous streams, have been utilized to synthesize 
polymeric nanoparticles, such as nano-precipitated particles consisting of diblock copolymers.25 
Additionally, microfluidic devices possess the potential to finely control a given set of reaction or 
process parameters, in turn reducing batch-to-batch variability.26  
With a bulk or microfluidic solvent exchange process, selection of an appropriate organic 
solvent is vital to: (1) ensure complete dissolution of the amphiphilic polymers and (2) retain 
functionality of molecular cargos. Meeting both requirements severely limits the types of polymers 
used as a building block for micelles and vesicles and also requires efforts to seek or synthesize a 
good solvent via trial-and-error.27 Another potentially important factor for in solvent exchange is 
the balanced mixing of amphiphilic polymer, organic phase, and aqueous phase. For instance, 
60 
 
amphiphilic polymers with increased fraction of hydrophobic domains can rapidly precipitate 
during the solvent exchange process prior to nanoparticle assembly, leading to the formation of 
aggregates. However, to date, few efforts were made to systematically examine and resolve these 
potential challenges in particle assembly.  
This study therefore demonstrates the significant role of amphiphilic polymer mixing 
conditions in regulating polymeric micelle and vesicle assembly via combined chemical 
modification of amphiphilic polymers and mechanical control of the solvent exchange process. 
We hypothesized that chemical modification of an amphiphilic polymer to thermodynamically 
improve its solubility in a given organic phase is advantageous to form nanoparticles with desired 
morphology and size. In addition, the microfluidic solvent exchange rate regulated by the 
volumetric flow rate ratio (termed FRR) between organic and aqueous phases would further 
mediate the self-assembly of amphiphilic polymers.  
We examined this hypothesis by using a poly(2-hydroxyethyl)aspartamide (PHEA) polymer 
substituted with a controlled number of octadecyl chains (C18) as a model amphiphilic polymer. 
The degree of substitution of C18 (DSC18) was varied in order to create a polymeric micelle or 
vesicle. We modified the alkylated PHEA with a controlled number of oligovaline chains to control 
the solubility of the polymer in an organic solvent such as dimethylformamide (DMF). The solvent 
exchange rate was modulated by introducing the PHEA polymers dissolved in DMF into an 
aqueous phase either by dropwise addition, termed off-chip mixing, or flow focusing in a 
microfluidic mixer, termed microfluidic or on-chip mixing, at different volumetric flow rate ratios 
between DMF and water (Figure 4.1).  
The critical role of oligovaline in improving polymer solubility was examined via a 
thermodynamic analysis. The role of oligovaline in nanoparticle formation was evaluated by 
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quantifying the energy of mixing via computational simulation and experimentation. The 
microfluidic mixing process was also examined via finite element model-based simulation and 
visualization of flow pattern. The morphology and average diameter of the resulting nanoparticles 
were evaluated with transmission electron microscopy (TEM). Overall, this study would serve to 
improve existing nanoparticle fabrication processes by expanding the parameter space available 
for self-assembly. 
 
4.2 Results and Discussion 
4.2.1 Synthesis of oligovaline-PHEA-C18  
First, PSI with an average molecular weight of 19,000 g/mol was prepared by acid-catalyzed 
polycondensation of aspartic acid.28 Then, a controlled number of octadecyl (C18) chains was 
conjugated to the PSI via the ring-opening nucleophilic addition of octadecylamine (Step 1 in 
Figure 4.2). Successful conjugation of the C18 chain was confirmed with the peak at 0.85 ppm on 
the 1H NMR spectra (Figure 4.3 and 4.4). The remaining PSI rings were then substituted with 
ethanolamine and ethylenediamine (Steps 2 and 3 in Figure 4.2). The degree of substitution for 
C18 to polymer (DSC18) was quantified with Equation 1. 
𝐷𝑆𝐶18 =
𝐴𝑟𝑒𝑎  𝑓𝑟𝑜𝑚 0.8 𝑡𝑜 0.94 𝑝𝑝𝑚
(𝐴𝑟𝑒𝑎 𝑓𝑟𝑜𝑚 4.3 𝑡𝑜 4.6 𝑝𝑝𝑚)∗3
× 100%                                          (4.1) 
According to the 1H NMR spectrum of the PSI substituted with C18, ethanolamine, and 
ethylenediamine (referred to as NH2-PHEA-C18), increasing the mass ratio between 
octadecylamine and succinimide units of the PSI from 0.28 to 0.56 led to an increase of the degree 
of substitution for C18 to polymer (DSC18) from approximately 20 to 40% (Equation 4.1, Figure 
4.3 and 4.4). 
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Separately, valine-n-carboxyanhydride (valine-NCA; structure in Figure 4.5) was prepared 
from the Fuchs-Farthing reaction.29 In this reaction, L-valine underwent ring-closure in the 
presence of triphosgene, resulting in valine-NCA.17 When valine-NCA reacted with the primary 
amines of NH2-PHEA-C18, the ring on valine-NCA was opened. This amine served as an initiator 
for the polymerization of the valine group, and an oligovaline chain was subsequently formed on 
NH2-PHEA-C18 (Step 4 in Figure 4.2).
31 The presence of oligovaline chains grafted to the PHEA-
C18 was confirmed by the distinctive 
1H-NMR peaks at approximately 1 ppm (Figure 4.3 and 
4.4).32 The number ratio of oligovaline chains to PHEA units was approximately 1:100 (0.01) for 
both DSC18 of 20% and 40%, as quantified by equation 4.2. 
𝑁𝑃𝐻𝐸𝐴/𝑣𝑎𝑙 =
𝐴𝑟𝑒𝑎 𝑓𝑟𝑜𝑚 1.01 𝑡𝑜 1.04 𝑝𝑝𝑚
(𝐴𝑟𝑒𝑎 𝑓𝑟𝑜𝑚 4.3 𝑡𝑜 4.6 𝑝𝑝𝑚)∗6
                                  (4.2) 
With a quantified value for DSC18, the hydrophilic mass fraction (f) of the PHEA polymers 
with DSC18 of 20% and 40% was approximated according to the following equation: 
𝑓 =
158(1−𝐷𝑆𝐶18)
158(1−𝐷𝑆𝐶18)+366𝐷𝑆𝐶18
          (4.3)  
Note that valine is neglected from this calculation, due to the low number ratio of valine groups 
to PHEA groups.33 At DSC18 of 20%, the f of oligovaline-PHEA-C18 was around 0.6. When DSC18 
was increased to 40%, f was lowered to about 0.4. Previous theoretical and experimental studies 
have indicated that an amphiphilic polymer with an f smaller than 0.35-0.40 self-assembles to form 
a polymeric vesicle.34,35 Above this range, spherical or cylindrical micelles are typically formed. 
Therefore, we predicted that oligovaline-PHEA-C18 at DSC18 of 20% would form a micelle, while 
oligovaline-PHEA-C18 at DSC18 of 40% would form a vesicle.  
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4.2.2 Experimental solubility analysis of oligovaline-PHEA-C18 in DMF  
We then evaluated the solubility of the synthesized amphiphilic PHEA molecules in DMF.  
Polymer solubility in the organic phase is a key consideration for solvent exchange, as the process 
involves the transitioning of the amphiphilic polymer from a region of high solubility to a region 
of low solubility. Note that other solvents, such as chloroform or hexane, were not considered 
because the organic solvent used for self-assembly must be miscible in water in order to enable 
solvent exchange. 
The PHEA substituted only with C18 chains and amine groups, termed NH2-PHEA-C18, formed 
a cloudy, insoluble dispersion in DMF (Figure 4.6a-i and 4.6a-ii).  The addition of the oligovaline 
chain to NH2-PHEA-C18 dramatically improved solubility of the polymer in DMF. At both DSC18 
of 20 and 40%, a clear yellow-brown solution was made at 30 mg/mL (Figure 4.6a-iii and 4.6a-
iv). According to measurements of polymer solubility at 0˚ C, NH2-PHEA-C18 (DSC18 =20 %) had 
a maximal solubility of only 7 mg/mL, while oligovaline-PHEA-C18 (DSC18 =20%) had a maximal 
solubility of around 44 mg/mL. Similar results were obtained for oligovaline-PHEA-C18 (DSC18 = 
40%) and NH2-PHEA-C18 (DSC18 = 40%) at 0 ˚C, as well as for oligovaline-PHEA-C18 (DSC18 = 
20%) and NH2-PHEA-C18 (DSC18 = 20%) at -20 ˚C and 25 ˚C.  
To examine underlying mechanism by which the oligovaline group improved the solubility of 
the NH2-PHEA-C18, the thermodynamic properties related to solvation were quantified. Based on 
the mass of polymers dissolved in DMF at 0 ˚ C, the Gibbs free energy change during mixing 
(∆Gmix) was calculated using the following equation:  
∆𝐺𝑚𝑖𝑥 =  −𝑅𝑇 ln 𝐾𝑒𝑞               (4.4) 
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Whereby R is the gas constant (8.314 J/mol-K), and T is temperature (K). Keq is defined as: 
𝐾𝑒𝑞 =
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑃𝐻𝐸𝐴 𝑝𝑜𝑙𝑦𝑚𝑒𝑟 𝑖𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
𝐼𝑛𝑠𝑜𝑙𝑢𝑏𝑙𝑒 𝑚𝑎𝑠𝑠 𝑜𝑓 𝑃𝐻𝐸𝐴 𝑝𝑜𝑙𝑦𝑚𝑒𝑟 
        (4.5) 
For the temperatures considered, ∆Gmix for oligovaline-PHEA-C18 was negative, whereas 
∆Gmix for NH2-PHEA-C18 was positive (Figure 4.6b). This trend suggests that the solvation of 
oligovaline-PHEA-C18 in DMF was more thermodynamically favorable than that of NH2-PHEA-
C18.  
Separately, using the Flory-Huggins solution theory, the entropy of mixing (∆Smix) was 
calculated based on the volume fraction of the oligovaline-PHEA-C18 or NH2-PHEA-C18 dissolved 
in DMF: 
∆𝑆𝑚𝑖𝑥 =  −𝑅 (𝜑1 𝑙𝑛 𝜑1 +
1
𝑁2
𝜑2 𝑙𝑛 𝜑2)                         (4.6) 
whereby φ1 is the volume fraction of DMF, φ2 is the volume fraction of PHEA-based polymer, and 
N2 is the degree of polymerization of PHEA (approximated as 190).
36  For both oligovaline-PHEA-
C18 and NH2-PHEA-C18, the entropy of mixing is positive, suggesting a higher amount of disorder 
as the polymer goes into solution. At 0 ˚C, ∆Smix for oligovaline-PHEA-C18 was approximately 5-
fold larger than ∆Smix for NH2-PHEA-C18 (Figure 4.6b). This increase in ∆Smix is likely due to the 
higher total fraction of PHEA polymer solubilized for oligovaline-PHEA-C18 than that for NH2-
PHEA-C18. Then, the enthalpy of mixing (∆Hmix) was approximated based on ∆Gmix (equation 4.4) 
and ∆Smix (Equation 4.7): 
 ∆𝐻𝑚𝑖𝑥 =  ∆𝐺𝑚𝑖𝑥 + 𝑇∆𝑆𝑚𝑖𝑥                                (4.7) 
According to the calculation, ∆Hmix for oligovaline-PHEA-C18 was negative (exothermic), and 
∆Hmix was positive (endothermic) for NH2-PHEA-C18 (Figure 4.6b). The change from an 
endothermic to an exothermic enthalpy of mixing is likely due to the change in intermolecular 
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interactions between PHEA polymer and DMF as the oligovaline chain is conjugated onto the 
polymer backbone.  
 
4.2.3 Molecular simulation of oligovaline-PHEA-C18 and NH2-PHEA-C18 solubility  
To further examine the role of the oligovaline groups on polymer solubility, the energy of 
mixing per unit volume (ΔEmix/V) of the model PHEA polymer with 11 repeating units was 
computationally calculated using the following equation.37 
∆𝐸𝑚𝑖𝑥
𝑉
= 𝜙𝑃𝐻𝐸𝐴 (
𝐸𝑐𝑜ℎ
𝑉
)
𝑃𝐻𝐸𝐴
+ 𝜙𝑆𝐷𝑀𝐹 (
𝐸𝑐𝑜ℎ
𝑉
)
𝑆
− (
𝐸𝑐𝑜ℎ
𝑉
)
𝑃𝐻𝐸𝐴−𝑆
    (4.8) 
Here, 𝜙𝑃𝐻𝐸𝐴 and 𝜙𝑆 are volume fraction of the PHEA-based polymer and solvent (i.e., DMF 
or water), respectively.  (
𝐸𝑐𝑜ℎ
𝑉
)
𝑃𝐻𝐸𝐴
, (
𝐸𝑐𝑜ℎ
𝑉
)
𝑃𝐻𝐸𝐴
, and (
𝐸𝑐𝑜ℎ
𝑉
)
𝑃𝐻𝐸𝐴−𝑆
are the cohesive energy density 
values of the pure PHEA, solvent, and the PHEA in the solvent, respectively. For all polymers 
including oligovaline-PHEA-C18 and NH2-PHEA-C18, the negative energy of mixing indicates that 
DMF is a better solvent than water (Table 4.1). Also, the oligovaline-PHEA-C18 exhibited a more 
negative energy of mixing, thus indicating a higher solubility in DMF. While the scope of the MD 
simulation was limited to a polymer with 11 repeating units for ease of computation, the 
computational results suggested that the oligovaline chain plays an important role in increasing 
the solubility of PHEA in DMF. 
We propose that this improved solubility of the oligovaline-PHEA-C18 is due to favorable 
intermolecular association between the polymer and DMF. The amide groups of the oligovaline 
chains coupled to the NH2-PHEA-C18 likely formed hydrogen bonds with DMF, a hydrogen bond 
acceptor (Figure 4.7). Thus, the oligovaline groups coupled to PHEA likely increased the number 
of hydrogen bonds between polymers and DMF, thus improving solubility.38 Without this 
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additional hydrogen bonding, van der Waals interactions between the octadecyl chains resulted in 
insoluble aggregates in DMF.39   
 
4.2.4 Determining mixing efficiency of the microfluidic mixer  
Separately, a PDMS microfluidic mixer was prepared, with a port for an aqueous phase 
(marked with A in Figure 4.8) and a port for the DMF dissolved with amphiphilic PHEA polymers 
(marked with D in Figure 4.8). DMF and the aqueous phase were mixed at different ratios starting 
at the flow focusing junction (zoomed-in region depicted in Figure 4.8c). Here, the volumetric 
flow rate of the aqueous phase to the volumetric flow rate of the DMF phase was denoted as the 
flow rate ratio (FRR). The mixed solution then traveled through a straight channel followed by a 
curved channel with a single outlet (marked with O in Figure 4.8a) to collect the PHEA-DMF-
water mixture.  All experiments and computational on-chip studies examined FRR at 5, 10, and 
20, with a constant total volumetric flow rate of 140 µL/min.  
COMSOL simulations were first conducted to estimate the mixing of DMF and water in the 
microfluidic device. For all FRR values, the Reynold’s number (eq 4.9) was kept constant at 14, 
thus indicating that all microfluidic mixing will be done in a laminar region. In contrast, the 
Reynold’s number for off-chip mixing (eq 4.10) is over 3,000, suggesting a mostly turbulent 
mixing regime.40 To quantify the mixing conditions on-chip, the Navier-Stokes and convective-
diffusive equations were used (eq 4.11-4.13). According to the surface plots generated from the 
COMSOL simulation, the concentration of DMF decreased more rapidly as FRR increased (Figure 
4.9a).  
The simulation was also used to estimate the percent mixing, coefficients of variation, and 
mixing times. For ease of calculation, all values were reported for the channel beyond the dashed 
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orange bar in Figure 3c, which is considered the end of the flow focusing region. Percent mixing 
is defined as the relative amount of DMF dissolved in the water phase; for a percent mixing of 
100%, all DMF added to the chip is evenly mixed with water (i.e., a homogenous solution). For 
FRR-20, 65% of DMF is mixed with water immediately after the flow focusing region. 
Conversely, for FRR-5, only 33% mixed of DMF is mixed with water. Despite these initial 
differences, all solutions were predicted to be well-mixed (i.e., percent mixed greater than 95%) 
through 5 mm after the flow focusing region (Figure 4.9b). 
Coefficient of variation (COV), a parameter which represented the deviation from complete 
mixing, was quantified using Equation 4.14 and Equation 4.15. COV followed a similar trend from 
a highly unmixed state to a mixed condition (Figure 4.9c). For FRR-20, COV starts at about 1.8 
which is higher than COVs for FRR-5 and FRR-10. At about 6 mm after the flow focusing region, 
all COV values fall below 0.2, indicating a near-complete mixing of DMF and water. The mixing 
time, defined as the time for 95% of DMF being mixed with water, was estimated to be around 28 
ms for FRR-5. The mixing time decreased to around 13 ms at FRR-20 (Figure 4.9d).  
In addition, the role of FRR on the mixing of DMF and water was experimentally examined 
by using DMF mixed with a colorant. As FRR increased from 5 to 10 and 20, the diameter of DMF 
stream in the aqueous phase became increasingly smaller, as determined with brightfield images 
(Figure 4.10). Notably, the initial stream diameter decreased as FRR increased. For FRR-5, the 
DMF stream diameter was 50 µm. At FRR-10 and FRR-20, the DMF stream diameter reduced to 
36 and 29 µm, respectively.  
As demonstrated from the surface plot of DMF/water generated from the COMSOL simulation 
(Figure 4.9a) and the brightfield microscope images of the microfluidic chip in operation (Figure 
4.10a), the mixing rate of DMF with water is slowest for FRR-5. Similarly, the DMF concentration 
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past the flow focusing region was noticeably higher when compared to similar regions in the FRR-
10 and FRR-20 conditions (Figure 4.9a).  
Based on these observations, it is likely that the high DMF concentration (13% by volume 
when fully mixed in water) at FRR-5 potentially leads to a heterogeneous micelle population. 
Therefore, on-chip mixing was performed only at FRR-10 and FRR-20, whereby the final DMF 
concentration is 10% by volume or less in a fully-mixed condition. We anticipated that micelle 
self-assembly would occur under more homogenous solvent conditions if the final DMF 
concentration is within this range, in turn leading to a monodisperse population of micelles.   
 
4.2.5 Polymeric micelle assembly  
PHEA solutions were injected into the microfluidic chip at different FRR while keeping total 
volumetric flow rate constant. In particular, DMF dissolved with the oligovaline-PHEA-C18 with 
DSC18 of 20% was mixed with the aqueous phase at FRR of 10 and 20. Separately, the aqueous 
phase was introduced into the DMF-polymer solution dropwise in order to prepare micelles via 
off-chip precipitation. Independent of FRR and particle assembly process, oligovaline-PHEA-C18 
formed a micelle, as confirmed with TEM images (Figure 4.11a). Interestingly, the average 
diameter of the micelles prepared with the microfluidic mixer ranged from 100 to 200 nm, while 
the average diameter of the micelles prepared with the off-chip precipitation was around 300 nm 
(Figure 4.11a-ii to 4.11a-iv). More interestingly, as FRR increased from 10 to 20, the micelle 
diameter was decreased from 200 to 100 nm (Figure 4.11b).    
In contrast, a PHEA-C18 (DSC18 of 35%) solution introduced into the microfluidic chip operated 
at FRR-20 failed to form micelles. The mixture was simply precipitated in the water-DMF mixture, 
thus forming large, irregular aggregates as shown in TEM images (Figure 4.11a-iv).  In addition, 
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solutions of oligovaline-PHEA free of C18 chains and solutions of NH2-PHEA-C18 could not form 
micelles with off-chip mixing (Figure 4.12a and 4.12b), suggesting that both a high degree of 
hydrophobicity (from the octadecyl chains) and a high solubility in the organic solvent (from the 
oligovaline group) is necessary for self-assembly in a DMF/water solvent exchange.  
These differences in micelle sizes can be explained by comparing the rate at which DMF and 
water mix with the rate at which polymer chains self-assemble to form a micelle.  As confirmed 
with computational simulations and experimental visualization, increasing FRR decreases the 
mixing time of DMF and water and also the volume fraction of DMF in the DMF/water mixture. 
As a consequence, it is likely that the octadecyl chains of oligovaline-PHEA-C18 should be driven 
to self-associate to form the micelle core more quickly at the higher FRR, thus resulting in the 
micelles with a smaller diameter.41  
 
4.2.6 Vesicle assembly  
In addition, the microfluidic mixing and the off-chip precipitation were used to prepare a 
polymeric vesicle. In this study, oligovaline-PHEA-C18 with DSC18 of 40% was used. With the off-
chip precipitation, the polymers formed a hollow vesicle with an average diameter of around 100 
nm (Figure 4.13). In the resulting TEM images, a dark bilayer with a thickness of around 20 nm is 
clearly denoted. However, polymeric vesicles could not be formed with the microfluidic mixing. 
When mixing DMF with oligovaline-PHEA-C18 in the microfluidic mixer, a brown precipitate was 
formed rapidly near the flow focusing region (Figure 4.14). At both FRR-10 and FRR-20, small, 
irregular nanoparticles without a noticeable bilayer and a diameter from 20 to 40 nm were found 
in TEM images (Figure 4.13b and 4.13c). Similar results were demonstrated even when the 
oligovaline-PHEA-C18 concentration in DMF was lowered from 30 mg/mL to 15 mg/mL. In 
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addition, a NH2-PHEA-C18 (DSC18=40%) solution mixed with water via off-chip mixing and a 
NH2-PHEA-C18 solution mixed with water at FRR-20 failed to form stable particles (Figure 4.12c 
and Figure 4.13d).     
We propose that increasing DSC18 of the oligovaline-PHEA-C18 from 20 to 40% significantly 
elevated the hydrophobicity of the polymer. In turn, the polymers dissolved in DMF may rapidly 
precipitate upon contacting with the water phase, as observed with brown-colored precipitates at 
the point of mixing (Figure 4.14). With a higher degree of hydrophobicity, the diffusion coefficient 
of oligovaline-PHEA-C18 with DSC18 of 40% in a DMF-water mixture is likely lower than that of 
oligovaline-PHEA-C18 with DSC18 of 20%, in turn leading to the rapid precipitation of polymer in 
the flow focusing region as well as the downstream channel.42,43  However, the off-chip mixing 
takes place under turbulent flow whereby convection dominates polymer transport, thus driving 
polymers to self-assemble into a vesicle. This interesting result is different from previous studies 
which have demonstrated that nano-sized liposomes could be formed in a 2D microfluidic flow 
focusing device, likely due to different molecular size and subsequent diffusivity of the lipids 
used.44    
 
4.3 Conclusion  
In conclusion, the solubility of the amphiphilic polymers in an organic phase and the laminar 
flow-based microfluidic mixing process contribute to regulating size of polymeric micelles in an 
orchestrated manner. The oligovaline groups conjugated to the NH2-PHEA-C18 contributed to 
thermodynamically improving the solubility of the polymer in DMF, likely due to increased 
hydrogen bonds between polymer and DMF. Moreover, the microfluidic mixer enabled us to mix 
laminar streams of DMF and water at controlled rates. Subsequently, increasing the mixing rate in 
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the microfluidic mixer decreased the size of micelles formed by the oligovaline-PHEA-C18 with 
DSC18 of 20%. In contrast, the microfluidic mixing failed to form a vesicle constituted with the 
oligovaline-PHEA-C18 (DSC18 of 40%). This result was attributed to the imbalanced diffusion of 
DMF and polymer into the water phase in the laminar flow mixing. To the best of our knowledge, 
this study is one of the first attempts to regulate nanoparticle fabrication by orchestrating solubility 
of particle-forming polymers and microfluidic mixing. We also propose that this study presents a 
unique approach, whereby polymer solubility and mixing conditions are independently controlled. 
We envision that the orthogonal approach demonstrated in this study will be broadly useful to 
understanding and further improving the quality of nanoparticles formed from a wide array of 
amphiphilic polymers of interest.  
 
4.4 Materials and Methods   
All chemicals were purchased from Sigma-Aldrich and used without purification, unless 
otherwise noted. Unless noted, all water was high-pressure liquid chromatography (HPLC) grade 
water (Macron).  
 
4.4.1 Synthesis of polysuccinimide (PSI)  
First, 50 g of L-aspartic acid was dissolved in 160 g of warm sulfolane under vigorous stirring. 
The temperature was gradually brought to 170 ° C under nitrogen. Then, 1.1 mL of 85% 
phosphoric acid (Fisher) was added to the reaction mixture as a catalyst.  A glass outlet was added 
to the reaction flask to remove excess water from the reaction. After reaction for about 7 hours, 
the reaction mixture was cooled to room temperature. The reaction mixture was then precipitated 
with 200 mL of methanol (EMD), and then several times with 200 mL of DI water. The excess 
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water from each washing step was tested with a pH strip (Hydrion). Here, a neutral pH reading 
confirmed removal of any impurities. Afterwards, the precipitate was loaded into a dialysis bag, 
and then dialyzed against DI water (MWCO 12,000-14,000, Fisherbrand). The dialysis water was 
changed approximately every 12 hours. Afterwards, the precipitate was removed from the dialysis 
bag, frozen at -20 ° C, and then lyophilized to form a dry powder (Labconco Freezone 6). 
 
4.4.2 Synthesis of NH2-PHEA-C18  
First, 291 mg of PSI was dissolved in DMF (ACS grade) at a concentration of 20-25 mg/mL. 
Then, 81 or 162 mg of octadecylamine was added to reaction mixture to form PHEA-C18 with a 
degree of substitution of octadecyl chains (DSC18) of 20% or40%, respectively. After reaction for 
at least 12 hours under nitrogen at 70 ˚ C, the reaction mixture was cooled to room temperature. 
Then, 161 µL (for DSC18 of 20%) of ethanolamine and 136 µL (for DSC18 of 40 %) of ethanolamine 
were added dropwise and then reacted for another 24 h. Afterward, a dilute solution of excess 
ethylenediamine was prepared in dry DMF. Then, the reaction mixture was slowly added to the 
ethylenediamine solution over several minutes. For this step of the reaction, the molar ratio of 
ethylenediamine to unreacted PSI rings was at least 5:1. After reacting for 3 hours at room 
temperature, the reaction mixture was dialyzed for at least 2 days against DI water (MWCO 
12,000-14,000, Fisherbrand), frozen, and then lyophilized to form a dry powder (Labconco). 
 
4.4.3 Synthesis of valine-N-carboxyanhydride (valine-NCA)  
First, 1.2 g of L-valine was dissolved in 12 mL of tetrahydrofuran (THF). Separately, 1.2 g of 
triphosgene was added to 2 mL of THF, and then added to the L-valine solution dropwise. The 
reaction mixture was then kept at 40 oC for 3 hours under nitrogen. Afterwards, the reaction 
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mixture was cooled and then vacuum-filtered to remove any insoluble material. The filtrate was 
then added to 300 mL of hexane, and then crystallized at -20 oC. 
 
4.4.4 Synthesis of oligovaline-PHEA-C18  
First, 165 mg of NH2-PHEA-C18 with DSC18 of 20% and 200 mg of NH2-PHEA-C18 with DSC18 
of 40% were separately dissolved in 3 mL DMF, and then slowly heated to 60 ˚ C. In parallel, 29 
mg and 72 mg of valine-N-carboxyanhydride (valine-NCA) were dissolved in 1 mL of DMF. 
These solutions were then added dropwise to the mixture of NH2-PHEA-C18 with DSC18 of 20% 
and 40%, respectively. After reacting at 60 ˚  C for at least 24 h under nitrogen, the reaction mixture 
was dialyzed (MWCO 3,500, Fisherbrand) against DI water for at least 2 days, while changing 
water at least three times. The sample was then frozen and lyophilized to form a dry powder 
(Labconco).  
 
4.4.5 NMR analysis of oligovaline-PHEA-C18  
Oligovaline-PHEA-C18 was dissolved in DMSO-d6 (Cambridge Isotope Laboratory) at a 
concentration of at least 10 mg/mL, and then loaded into an NMR terialsube (Varian VXR 500). 
To improve the height of the analyte peaks, solvent saturation was used as needed. All scans were 
done at 35 ˚ C, and at least 20 scans were taken per sample. All spectra were processed with 
ACDLABS 12.0 software.   
 
4.4.6 Molecule dynamics simulation of PHEA solubility  
Molecular dynamics (MD) simulations were employed to study the effect of the oligovaline 
chains on the solubility of NH2-PHEA-C18 and oligovaline-PHEA-C18. All computational 
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calculations were performed using Materials Studio simulation software (version 8.0) from 
BIOVIA equipped with COMPASS II force field.45 Coulomb interactions were calculated using 
Ewald summation, and van der Waals interactions were determined using an atom-based 
summation method (15.5 Å cutoff distance). 
Two model polymers with 11 units were examined, with side chain compositions of (i) 
hydroxyethyl:C18:aminoethyl = 8:2:1 (for NH2-PHEA-C18), and (ii) hydroxyethyl:C18:oligovaline 
= 8:2:1 (for oligovaline-PHEA-C18) (Figure 4.15). The cohesive energy densities of pure polymers, 
solvents (DMF or water), and polymers in solvents were obtained through the MD simulation to 
ultimately calculate the energy of mixing per unit volume. A polymer concentration of 30vol% 
was selected. Each model polymer was first optimized using Forcite module, and the optimized 
structure was packed into a lattice typically ca. (50 Å)3 (density 1 g/cm3) using the Amorphous 
Cell module. Once the lattice was energetically minimized, MD method was implemented for 100 
ps with 1 fs time step. The NVT ensemble (Nosé thermostat) was used at 298 K (Q ratio: 0.01).46 
The initial 50 ps was for equilibration, and the later 50 ps was for data sampling at 10 ps interval. 
MD calculations were similarly performed for pure solvents and polymers with 11 units (30vol%) 
in solvents. Each case was simulated at least three times starting from independent initial 
structures, and the lowest energy result was chosen for the sampling of five structures. The reported 
values of cohesive energy density and the energy of mixing per unit volume were the average from 
five sampled structures.  
 
4.4.7 Synthesis of oligovaline-PHEA-C18 and PHEA-C18-NH2 labeled with fluorescein 
isothiocyanate (FITC) 
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Briefly, oligovaline-PHEA-C18 and PHEA-C18-NH2 were dissolved in DMF. Then, a solution 
of fluorescein isothiocyanate (FITC) was added dropwise to the polymer solution. The mass ratio 
of PHEA polymer to FITC was kept at approximately 1:0.0006. The reaction continued for 24 h 
at room temperature (for oligovaline-PHEA-C18) or 24 h at 60 ˚ C (for PHEA-C18-NH2). Afterward, 
the reaction mixtures were dialyzed (MWCO 3,500, Fisherbrand) against DI water for 48 hours; 
fresh DI water was added at least twice. 
 
4.4.8 Determination of maximal solubility of PHEA  
Oligovaline-PHEA-C18 and NH2-PHEA-C18 labeled with FITC were dissolved in DMF at 
varying concentrations ranging from 0 to 250 µg/mL. Then, a linear calibration curve was 
established for each polymer functionalized with FITC by measuring polymer concentration versus 
the fluorescence intensity at 485 nm (Tecan Infinite 200 PRO plate reader; gain set to 50). To 
determine the maximal solubility of oligovaline-PHEA-C18 and NH2-PHEA-C18, a mass of 
polymer (5-15 mg) was placed in a clean glass scintillation vial, and then dissolved at a given 
concentration (50 mg/mL for oligovaline-PHEA-C18, or 15 mg/mL for NH2-PHEA-C18). Then, the 
vial was mechanically agitated briefly, then incubated for 1 h at -20, 0, or 25 ˚C. After incubation, 
the polymer solution was separated from the insoluble polymer with centrifugation (two minutes 
at 10,000 rcf; Eppendorf centrifuge 5424). The mass of insoluble polymer was then dissolved in a 
large volume of DMF overnight at room temperature in the dark, and the fluorescent intensity of 
the resulting solution was then taken at 485 nm. The concentration of soluble and insoluble 
polymer was then back-calculated using the established calibration curve and a mass balance 
equation.  
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4.4.9 Mold fabrication for microfluidic devices 
Molds for replicating polydimethylsiloxane (PDMS) microfluidic devices were fabricated 
using standard photolithography procedures. Three-inch silicon wafers (University Wafer) were 
cleaned by rinsing with acetone then isopropanol and dried by blowing nitrogen over the wafers.  
Cleaned silicon wafers were then heated on a hot plate at 115 °C for 3 min and cooled by blowing 
nitrogen over the wafers.  SU-8 2050 photoresist (MicroChem Corp.) was spin-coated onto the 
wafers to a final thickness of roughly 100 μm. The SU-8 coated silicon wafers were baked on hot 
plates for 5 min at 65 °C, then 17 min at 95 °C, and finally 2 min at 65 °C.  Wafers were then 
placed inside a UV exposure system (OAI).  A transparency mask, made using Adobe Illustrator 
CS5 (Adobe Systems Incorporated,) and printed by Fineline Imaging (Fineline Imaging), was 
placed on top of the SU-8. A PL-360LP filter (Omega Optical, Inc.) was placed on top of the 
transparency to reduce air gaps between the mask and SU-8, and reduce T-topping from short 
wavelength (<350 nm) light.  The wafers were then exposed to UV light (5.44 mW/cm2) for 47 
seconds.  The UV exposed SU-8 wafers were placed on a hot plate and the temperature was ramped 
from room temperature to 55 °C at 2 °C/min.  Wafers were then baked for 2 h at 55 °C, allowed 
to cool to room temperature, and then developed by gently swirling in propylene glycol 
monomethyl ether acetate (PGMEA) for about 10 min. Developed wafers were rinsed with 
PGMEA, then isopropanol, and dried by blowing nitrogen over the wafers. Wafers were then 
coated with perfluorodecyl-1H,1H,2H,2H-trichlorosilane (Gelest) via vapor deposition to prevent 
adhesion of PDMS to the mold. 
4.4.10 Nanoparticle-extruding microfluidic device fabrication  
PDMS replicates were made by mixing RTV615 (Momentive Performance Materials,) or 
Sylgard 184 (Dow Corning) base and curing agent at a 10:1 ratio. The mixture was degassed in a 
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vacuum desiccator for ~20 minutes, poured on a mold inside a petri dish, and placed in an oven at 
65 °C for 2 hours to cure the PDMS. The PDMS was peeled off the mold and holes were punched 
at the inlets and outlet using 19 gauge hypodermic tubing with a beveled end. A glass slide 
(Thermo Fisher Scientific Inc.) was cleaned with the Alconox solution, rinsed with water (18.0 
MΩ cm), and dried with nitrogen. Oxygen plasma was used to activate the PDMS and glass slide 
surfaces to ensure stable bonds between PDMS and glass. Then, the PDMS replicate was pressed 
against the glass slide and incubated in an oven at 65 °C overnight. 
 
4.4.11 COMSOL simulation to characterize on-chip mixing  
Reynolds number was calculated using the following formula:  
Re =  
𝑣𝑙
𝜈
           (4.9) 
 where v, l, and υ are total linear flow velocity, characteristic length scale, and kinematic 
viscosity in the outlet channel, respectively. Reynolds number for the off-chip mixing was 
calculated using the equation for a stirred tank47: 
Re =
 𝜌𝑁𝐷2
µ
           (4.10) 
Whereby 𝜌 is the density of DMF (0.9446 g/mL), µ is the viscosity of DMF (0.846 mPa-s), N is 
the rotational speed (1,000 rpm), and D is the diameter of the agitator (12.7 mm). 
“Single-phase laminar flow” and “transport of diluted species” modules were coupled in 
COMSOL in order to solve Naviér-Stokes (N-S) equation and convective-diffusion, respectively 
for incompressible fluid. The governing equations are as follows: 
Naviér-Stokes equation: 
𝜌(𝑣. ∇)𝑣 −  ∇. 𝜂(∇𝑣 + (∇𝑣)𝑇) +  ∇𝑝 = 0        (4.11) 
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∇. 𝑣 = 0            (4.12) 
Convective-Diffusion equation: 
𝒟∇2𝑐 − 𝑣. ∇𝑐 = 0          (4.13) 
In the above equations, ρ denotes density (kg/m3), 𝑣 is the velocity vector (m/s), η denotes 
viscosity (Pa s), p equals pressure (Pa), 𝒟 denotes the diffusion coefficient (m2/s) and c represents 
the concentration (mol/m3). The following fluid properties were used in the simulation; water – 
density: 1,000 kg/m3, dynamic viscosity: 0.89 mPa-s, concentration: 55,400 mol/m3; DMF – 
density 9,446 kg/m3, dynamic viscosity: 0.864 mPa-s, concentration: 12,900 mol/m3. The 
diffusion coefficient was kept as 10-9 m2/s for both water and DMF, which is in agreement with 
the common values found in literature.48  
Simulations were performed for three different water/DMF flow rate ratios (FRRs) – 5:1, 10:1, 
20:1 – while the total volumetric flow rate was kept constant. Maximum triangular mesh element 
size was fixed at 0.03 mm for all the simulations. Also, mesh for all the simulations were calibrated 
for fluid dynamics physics. The total number of mesh-elements was constant across all the 
simulations with 16,444 elements, 94 vertex elements, and 2,265 boundary elements.  
The concept of covariance (CoV) was used in order to estimate the level of mixing. CoV, in 
layman terms, indicates the extent of variation of a quantifiable entity (concentration in this case) 
in an ensemble. Therefore, a lower CoV represents lower ensemble variation and consequently, 
high uniformity. Essentially, a lower CoV represents a higher level of “mixedness” and vice versa 
in this case. Furthermore, we considered 95% mixing as the state of complete mixing.48 CoV was 
calculated at different positions in the outlet channel (past the flow focusing region) for various 
flow rate ratios to account for differences in the extent of mixing. The mixing times were estimated 
by calculating the time required to reach 95 % mixing for each different FRR. 
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√∫ (𝑐−?̅?)
2.𝑑𝑙
0.2
0
0.2
𝑐̅
                   (4.14) 
In the above equation, c denotes the concentration of DMF in the outlet channel where the CoV 
is evaluated and 𝑐̅ denotes the concentration of DMF in a fully mixed state that is calculated using 
the following formula: 
𝑐̅ =  
𝑣𝐷∗𝑐𝐷
𝑣𝑤+ 𝑣𝐷
           (4.15) 
In the above equation, 𝑣𝐷 and 𝑣𝑤 are the linear velocities of DMF and water in the outlet 
channel, respectively. 𝑐𝐷 is the concentration of DMF at the inlet (12,900 mol/m
3).  
 
4.4.12 Preparation of PHEA nanoparticles using the microfluidic mixer  
Oligovaline-PHEA-C18 (DSC18 of 20% and 40%) was dissolved in DMF at a concentration of 
30 mg/mL. A 1 mL glass syringe containing 300 µL of the PHEA polymer solution was loaded 
onto a microliter syringe pump (Harvard Apparatus). Separately, a syringe charged with 10 mL of 
phosphate buffered saline (PBS, Corning Cellgro) was loaded onto a milliliter syringe pump 
(Harvard Apparatus). For both solutions, care was taken to remove air bubbles. Prior to use, 
microfluidic chips were flushed with isopropanol and then PBS at a flow rate of 30 µL/min to 
remove any air pockets. Then, PBS and oligovaline-PHEA-C18 in DMF were pumped through the 
chip at the following flow rates: 117 µL of PBS/min: 23 µL of DMF solution/min (FRR-5); 127µL 
of PBS /min:12.7 µL of DMF solution/min (FRR-10); 133 µL of PBS /min:7 µL of DMF solution 
/min (FRR-20). The outlet from the tube was collected in a centrifuge tube. Afterwards, the 
nanoparticles were washed twice in a 0.5 mL centrifugal filter (100,000 MWCO; Amicon 
Millipore) at 1,500 rcf for at least 10 minutes (Eppendorf centrifuge 5424), and each time re-
dispersed in water. In order to visualize the mixing conditions on-chip, the experiments described 
80 
 
above were repeated, but with DMF containing orange-red food coloring (McCormick). All 
images were captured with a light microscope (Leica M205 C).  For control on-chip mixing 
experiments, additional control PHEA polymers with DSC18 of 15% and 35% and no amine groups 
were prepared and then mixed at FRR-20. 
 
4.4.13 Off-chip preparation of PHEA nanoparticles  
Separately, 100 µL of oligovaline-PHEA-C18 solution was added into a 7 mL scintillation glass 
vial, and then stirred with a magnetic stir bar (12.7 mm diameter) at 1,000 rpm on a hot plate. 
Then, 1 mL of PBS was added in a drop-wise fashion to the PHEA solution over the course of 
approximately 15 to 30 seconds. The resulting particles were washed identically to the particles 
prepared on the microfluidic mixer. For a control off-chip mixing experiment, an oligovaline 
PHEA polymer was prepared with no octadecyl chains and then mixed off-chip.  
 
4.4.14 TEM imaging of PHEA nanoparticles  
PHEA nanoparticles were suspended in water at 0.75-1.5 mg/mL. Separately, a 20 mg/mL 
solution of phosphotungstic acid (PTA) was prepared and the pH was adjusted to a neutral range 
(6-8) with concentrated NaOH. Then, the PTA solution and the particle dispersions were mixed in 
a 1:1 volumetric ratio. Approximately 10 µL of this solution was quickly added to a 200 mesh 
carbon TEM grid (EMS) on top of a filter paper, and then dried in air for about 20 minutes before 
imaging. Images were captured (JEOL 2100) at 200 kV, with multiple images taken on at least 
three different sections of each grid.  
 
4.4.15 Image analysis of oligovaline-PHEA-C18 nanoparticles  
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All images were analyzed in ImageJ (NIH). Approximately 15 nanoparticles were analyzed 
per condition. To analyze the diameter of the PHEA-C18-valine, a straight line was drawn across 
the micelle image and then measured. To analyze the diameter and thickness of the PHEA-C18-
valine polymersomes, a region-of-interest (ROI) was defined separately for the outer and inner 
diameter of the polymersome. Then, Feret’s diameter was measured. The diameter of the 
polymersome was defined as the geometric mean of the Feret and MinFeret values of the outer 
oval. To quantify polymersome thickness, geometric mean of the Feret and MinFeret values were 
measured for the inner and outer ROIs, and then subtracted. 
 
4.4.16 Statistical analysis of data 
Statistical significance between all conditions was compared using a one-way ANOVA test 
with a post-hoc Tukey’s test (R Studio 3.2.2). 
 
 
 
 
 
 
 
 
 
 
 
4.5 Figures and Tables 
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Figure 4.1 Schematic depicting off-chip (a) and microfluidic/on-chip mixing (b) to prepare 
PHEA nanoparticles.  
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Figure 4.2 Schematic depicting the synthesis of polyaspartamide substituted with octadecyl and 
oligovaline groups (termed “Oligovaline-PHEA-C18”). The molar ratio of x, y, and z monomers is 
determined by changing the ratio of ethanolamine, octadecylamine, and ethylenediamine added in 
Step 1 to 3. Note that the distribution of x, y, and z in the polymer chain is random.  
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Figure 4.3 1H-NMR spectrum for oligovaline-PHEA-C18 (DSC18 = 20 %). Peaks are denoted for 
the PHEA backbone (4.5 ppm), the octadecyl chain (0.85 ppm), and valine (1.02 and 1.12 ppm). 
Note that the tan shaded area denotes the presence of water. 
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Figure 4.4 1H-NMR spectrum for oligovaline-PHEA-C18 (DSC18 = 40 %). Peaks are denoted for 
the PHEA backbone (4.5 ppm), the octadecyl chain (0.85 ppm), and valine (1.02 and 1.12 ppm). 
Note that the tan shaded area denotes the presence of water.  
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Figure 4.5 Structure of valine n-carboxyanhydride (valine-NCA) used to prepare valine chains. 
Structure confirmed with 1H-NMR (data not shown).  
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Figure 4.6 Effects of oligovaline on the solubility of PHEA in DMF. (a) Images of PHEA 
dissolved in DMF at 30 mg/mL. (i) NH2-PHEA-C18 (DSC18 = 20%); (ii) NH2-PHEA-C18 (DSC18 = 
40%); (iii) Oligovaline-PHEA-C18 (DS C18 = 20%); (iv) Oligovaline-PHEA-C18 (DS C18= 40%). 
(b) Changes in Gibbs free energy of mixing (ΔGmix), the heat of mixing (ΔHmix), and the entropy 
of mixing (ΔSmix) for oligovaline-PHEA-C18 (DS C18= 20%) and NH2-PHEA-C18 (DS C18= 20%). 
All values were calculated at 0 ˚C. 
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Table 4.1 The computationally simulated energy of mixing per unit volume for the oligovaline-
PHEA-C18 and the NH2-PHEA-C18 with 11 units dissolved in DMF or water at 30vol%. The unit 
for the energy per volume is J/cm3.  
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Figure 4.7 Proposed mechanism for the solubility changes that occur with the conjugation of the 
oligovaline chains to NH2-PHEA-C18. Without the oligovaline chains, the PHEA polymer 
associates with itself in insoluble aggregates (a). By conjugating oligovaline chains to NH2-PHEA-
C18, additional sites for hydrogen bonding with DMF are present in the polymer (b), thus enabling 
improved solubility in DMF. The dashed blue line (as depicted in inset) indicates the presence of 
hydrogen bonding between secondary amines on the valine chain and DMF.  
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Figure 4.8 CAD image depicting microfluidic mixer design. (a) CAD image of the entire chip 
design. “O” corresponds to the outlet for the mixed DMF/water streams. A region of interest 
(depicted in b) is denoted with a blue line. Yellow scale bar corresponds to 1 cm. (b) Zoomed-in 
image of the inlets of the chip. “D” corresponds to the inlet stream for DMF dissolved with 
polymer, and “A” corresponds to the inlet stream for the aqueous media. A region of interest 
(termed flow focusing region; depicted in c) is denoted with a blue line. Yellow scale bar 
corresponds to 2 mm. (c) Zoomed-in image of the flow focusing region. The dashed orange line 
corresponds to the starting point for the area considered for calculating the coefficient of 
variance and percent mixing in the COMSOL simulation. Yellow scale bar corresponds to 0.5 
mm.  For all images, the coordinates for the chip are defined as “x” (green arrow) and “y” (blue 
arrow). 
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Figure 4.9. Quantifying mixing conditions in the microfluidic mixer via COMSOL simulations. 
(a) Surface plots depicting changes in DMF concentration with respect to x-y (green-blue 
arrows) in the microfluidic mixer for FRR-5 (i), FRR-10 (ii), and FRR-20 (iii). DMF 
concentration ranges from 0 (blue in color in the surface plot) to 1.28 × 104 mol/m3 (red in color 
in the surface plot). The z-axis corresponds to DMF concentration as well.  (b) Percent mixed 
versus mixing length (y) for FRR-5, FRR-10, and FRR-20. (c) Coefficient of variation (COV) 
versus mixing length (y) for FRR-5, FRR-10, and FRR-20. Note that these plots only consider 
the region after the initial flow focusing zone (i.e., only the channel length after the dotted 
orange line in Figure 3c/Figure 5a is considered). (d) Mixing time and Reynold’s number values 
for FRR-5, FRR-10, and FRR-20. 
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Figure 4.10 Brightfield microscopy images of the microfluidic chip in operation. An orange food 
colorant is used to distinguish the DMF stream (labeled “D”) from the aqueous stream (labeled 
“A”). The flow rate ratio (FRR) varies from 5 (a) to 10 (b) and 20 (c). The black scale bar 
corresponds to 200 µm.  The green and blue arrows correspond to the x- and y-axis, respectively. 
The dashed orange line corresponds to the starting point of the area considered for calculating the 
COV and percent mixing in the COMSOL simulation. 
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Figure 4.11 TEM images and size analysis for PHEA micelles. (a) Oligovaline-PHEA-C18 
(DSC18=20%) micelles formed with off-chip mixing (i), with microfluidic mixer at FRR-10 (ii) 
and with microfluidic mixer at FRR-20 (iii).  Micelles were not formed with a separate polymer 
(PHEA-C18 with DSC18 of 15%) at FRR-20 (iv). The scale bar represents 100 nm. (b) Diameter 
of oligovaline-PHEA-C18 (DSC18 = 20%) micelles quantified with TEM images. At least 15 
particles were analyzed per condition. * represents the statistical significance of the difference 
between conditions (*p < 0.05). Values and bars correspond to averages and standard deviation 
of one set of measurements, respectively. 
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Figure 4.12 Transmission electron microscopy (TEM) images of polyaspartamide nanoparticles 
created as additional controls. Particles were fabricated via off-chip precipitation using 
oligovaline-PHEA (a), NH2-PHEA-C18 (DSC18 = 20 %) (b), or NH2-PHEA-C18 (DSC18 = 40 %) 
(c). Scale bar denotes 100 nm.   
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Figure 4.13 Oligovaline-PHEA-C18 (DSC18=40%) polymeric vesicles formed with the off-chip 
precipitation (a) and polymer aggregates formed from microfluidic mixing at FRR-10 (b) and 
FRR-20 (c). NH2-PHEA-C18 with DSC18 of 35 % could not form a polymersome with 
microfluidic mixing at FRR-20 (d). The white scale bars represent 100 nm. 
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Figure 4.14 Brightfield image of flow-focusing region after fabricating oligovaline-PHEA-C18  
(DSC18 = 40 %) nanoparticles. Scale bar corresponds to 1 mm. 
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Figure 4.15 Schematic of polymer with 11 units used to approximate PHEA molecules for 
molecular simulation.  
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CHAPTER 5: FLOW-MEDIATED STEM CELL LABELING WITH 
SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE CLUSTERS4 
 
5.1 Introduction  
Stem and progenitor cells possess the potential to treat various acute and chronic diseases and 
tissue defects, due to their multipotent differentiation capacity, trophic factor secretion, and 
immunosuppressive activities.1 In mesenchymal stem cell therapies, stem cells are isolated from a 
patient’s bone marrow or adipose tissue, expanded to therapeutic levels ex vivo, and then 
reinjected locally or systemically.2 To better understand and modulate cellular therapeutic 
activities, clinicians must assess the localization and bioavailability of transplanted cells in vivo 
using a clinical imaging modality, such as magnetic resonance imaging (MRI). 
Toward this goal, extensive efforts have been made to label stem cells ex vivo with 
superparamagnetic iron oxide nanoparticles (SPIONs), a popular T2 contrast agent capable of 
highly sensitive in vivo imaging.3 One emerging, simple method to modulate SPION size and 
                                                     
4 This chapter is adapted with permission from Clay, N.; Baek, K.; Shkumatov, A; Lai, M.; Smith, 
C.E.; Rich, M.; Kong, H. Flow-mediated Stem Cell Labeling with Superparamagnetic Iron Oxide 
Nanoparticle Clusters. Copyright 2013 American Chemical Society. This work was supported by 
the National Institute of Health (1R01 HL109192 to H.J.K. and R25 CA154015A to N.C.). We 
would like to thank Dr. Boris Odintsov for help with MR imaging, Dr. Mayandi Sivaguru for help 
with confocal and cell imaging, Dr. Wacek Swiech for help with TEM images, and Rudy Laufhutte 
for ICP measurements. Special appreciation is given to Ian Baek for optimizing the computational 
simulations used herein.  
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functionality for labeling is to cluster several SPIONs together using self-assembling polymers 
with diverse functional groups.4,5 In this way, a cluster is formed, containing multiple SPIONs 
surrounded by a polymeric coating already grafted with various biomolecules of interest. With this 
technique, the size of the SPION cluster can be controlled through the concentration and chemical 
structure of the self-assembling molecules, in turn allowing SPION clusters to be easily tuned for 
enhanced receptor-mediated endocytosis6 or maximum T2 relaxivity.
7 In addition, the cluster 
formation process avoids the extensive conjugation and purification steps required in the direct 
surface modifications of SPIONs.8–10 Despite the advantages offered by this clustering technique, 
advanced methods are still needed to increase SPION loading efficiency within cells, as cell 
proliferation and SPION exocytosis results in a gradual reduction of the MR signal in vivo, in turn 
limiting the long-term effectiveness of cell tracking.11 Therefore, we sought to develop a new 
method to tailor the cellular uptake of SPION clusters and improve cell tracking, apart from 
conventional approaches that rely on changes to SPION size, charge, and surface chemistry12 or 
potentially harmful external stimuli such as electroportation.13 With this strategy, we also seek to 
maintain cell viability and function. According to recent cell biology studies, the extracellular 
mechanical environment regulates the endocytosis and exocytosis of extracellular components 
both in vitro and in vivo.14 For example, shear flow has been shown to affect adhesion and 
endocytosis of quantum dots to endothelial cells.15 Aligned with these findings, we hypothesized 
that cells exposed to an external flow in vitro would ingest a greater amount of SPION clusters 
grafted with integrin-binding peptides. 
We examined this hypothesis by coincubating bone marrow-derived mesenchymal stem cells 
(BMSCs) with SPION clusters. These SPION clusters are coated with integrin-binding peptides 
containing an Arg-Gly-Asp (RGD) sequence. BMSCs were labeled with RGD-SPION clusters on 
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an orbital shaker rotating at controlled speeds, at which the average cluster velocity and shear 
stress on the cell membrane were estimated to increase. The resulting cell labeling efficiency was 
evaluated by measuring RGD-SPION clusters per cell using inductively coupled plasma (ICP) 
spectroscopy and independently confirmed by measuring the relaxivity of labeled BMSCs in a 
collagen gel. Finally, cell labeling under orbital flow was demonstrated by locally injecting 
BMSCs labeled with RGD-SPION clusters into the muscle of a mouse’s hindlimb and imaging the 
leg with MRI. Taken together, this study will serve to improve the effectiveness of cell tracking 
and, ultimately, the therapeutic activities of a wide range of cells. 
 
5.2 Results 
5.2.1 Synthesis of amphiphilic polyaspartamide and SPION clusters  
We first synthesized poly(2-hydroxyethyl aspartamide) (PHEA) grafted with octadecyl chains 
and RGD peptides (termed RGD-PHEA-C18) for use in SPION clustering. The octadecyl chains 
allow PHEA to associate with a hydrophobic moiety.5 Separately, the RGD peptides of PHEA 
bind with cellular integrin domains, including β1.16 The sequential addition of octadecylamine, 
GGGGRGDSP peptide, and ethanolamine to polysuccinimide (PSI) resulted in PHEA substituted 
with octadecyl chains, GGGGRGDSP, and hydroxyl groups, as confirmed through 1H NMR 
(Figures 5.1, 5.2, and 5.3a).17 The degree of substitution (DSC18) of octadecyl chain was 
approximately 6.7%, as calculated with 1H NMR. Next, the resulting RGD-PHEA-C18 was mixed 
with OA-SPIONs prepared from the thermal decomposition of iron acetylacetonate (Figure 3b).18 
Adding an aqueous solution of RGD-PHEA-C18 to OA-SPIONs suspended in chloroform resulted 
in RGD-SPION clusters. After removing the chloroform, the resulting clusters were readily 
suspended in DI water without noticeable aggregation (Figure 5.3c and 5.3d). Here, cluster 
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formation is driven by the intercalation of the oleic acid ligand from OA-SPIONs and the octadecyl 
chains of PHEA.19 The mean diameter of cluster was approximately 43 nm, as reported by DLS 
(Figure 5.4). A polydispersity index of less than 0.2 is reported, demonstrating a good degree of 
cluster size control. In addition, the RGD-SPION clusters were less than 50 nm in diameter, which 
was suggested as a size range to facilitate receptor-mediated endocytosis.6 The T2 relaxivity of 
RGD-SPION clusters was around 135 mM–1s–1 (Figure 5.3e), comparable to that of FDA-approved 
contrast agents such as Feridex.20 The RGD-SPION clusters suspended in PBS remained stable at 
4 °C for over three weeks. 
 
5.2.2 Computational simulation of SPION cluster velocity and orbital shear  
Separately, computational simulations and mathematical calculations were conducted to 
estimate the average velocity of RGD-SPION clusters and the shear stress on the cell membrane. 
According to a COMSOL simulation, the average velocity of RGD-SPION clusters in the static 
condition was around 0.2 mm (Figure 5.5). The cluster velocity was minimally changed by 
increasing the orbital speed to 20 rpm. Further increasing the orbital speed to 50 rpm resulted in a 
significant increase of cluster velocity to 1.5 mm/s, an order of magnitude difference from the 
speed in the static condition. 
In parallel, shear stress on the cell membrane was approximated by 
𝜏𝑤 = 𝑅√𝜌𝜇Ω3          (5.1) 
where R is the orbital radius of the shaker (20 mm), ρ is the density of the culture medium (0.9973 
g/mL), μ is the dynamic viscosity of the medium (0.0102 Pa-s), and Ω is the angular velocity 
(rad/s).21 
105 
 
According to this calculation, increasing the orbital speed from 0 to 20 and 50 rpm increased 
shear stress from 0 to 0.6 and 2.4 dyn/cm2, respectively (Figure 5.6). On the basis of previous 
studies, shear stress levels as low as 0.2 dyn/cm2 have been shown to influence cellular gene 
incorporation, suggesting that a minimum shear level is needed to stimulate cells.22 Alternatively, 
increasing the orbital speed past a certain limit, such as 100 rpm, was shown to cause extensive 
media drying due to the increasingly violent motion of the media.23 
 
5.2.3 Evaluation of stem cell labeling efficiency under shaking  
To assess whether or not shear stress and cluster velocity influenced RGD-SPION cluster 
uptake, we labeled BMSCs under orbital speeds ranging from 0 to 20 and 50 rpm. As hypothesized, 
BMSCs labeled at orbital velocity of 50 rpm took up more RGD-SPION clusters than those labeled 
under static conditions, as evidenced by Prussian blue staining (Figure 5.7a-I and 5.7a-II). An ICP 
analysis further confirmed a significant increase of the iron content per cell (Figure 5.7b). BMSCs 
labeled at 20 and 50 rpm took up a 1.6- and 1.8-fold greater amount of RGD-SPION clusters than 
those labeled under static condition, respectively. At 50 rpm, the iron content per cell was 
approximately 7 pg Fe, which was over four times larger than the widely accepted benchmark for 
cell tracking in vivo (i.e., 1.5 pg/cell).24 Note that the cellular uptake of RGD-SPION clusters was 
significantly increased even at an orbital velocity of 20 rpm, at which the cluster velocity was not 
significantly increased. Despite such high iron loading per cell, over 85% of cells remained viable 
across all orbital speeds, as determined through a Trypan Blue assay. This viability level was 
comparable to that of cells cultured in static conditions without RGD-SPION clusters, suggesting 
that neither shaking nor SPION loading affects viability.  
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These interesting effects of orbital flow on cell labeling efficiency became insignificant when 
the concentration of FBS in the cell culture media (ΦFBS) was decreased from 10% to 1%. As 
characterized with both Prussian blue staining and ICP, the iron content per cell was independent 
of orbital velocity (Figure 5.7a-III, 5.7a-IV, and 5.7c). Accordingly, the iron content per cell was 
independent of changes in cluster velocity and shear stress at low ΦFBS. In addition, for cells 
exposed to orbital flow, the iron content per cell was decreased by reducing ΦFBS from 10% to 1%. 
In contrast, labeling efficiency in static conditions was independent of ΦFBS. 
 
5.2.4 BMSC phenotype changes under orbital shear 
To further address the underlying mechanism by which the orbital velocity and the 
concentration of FBS (ΦFBS) affect the cellular uptake of RGD-SPION clusters, we first examined 
whether one or both of these experimental variables modulated the frequency of cellular division. 
According to previous gene transfection studies, more frequent cell division is correlated with 
improved uptake of plasmid DNA complexes.25 According to an MTT assay, decreasing ΦFBS to 
1% significantly limited cell metabolic activity and proliferation, as assessed with a decrease in 
the amount of MTT reagent reduced by metabolically active cells over time (Figure 5.8). However, 
at a given ΦFBS, the degree of increase in cell proliferation was independent of the orbital velocity. 
Therefore, the iron content per cell was not dependent on cell proliferation. 
In parallel, we examined the effects of orbital velocity and ΦFBS on β1 integrin cluster 
formation, as integrin clustering is reported to be a key step in the cellular incorporation of RGD-
coated gene complexes.26 Total cellular β1 integrin expression level was significantly reduced with 
decreasing ΦFBS (Figure 5.9). There was not a noticeable difference of the total β1 integrin 
expression between cells cultured in the static and shaking conditions at a given ΦFBS (Figure 5.9a 
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and 5.9b). In contrast, at ΦFBS of 10%, cells cultured under orbital flow displayed a large number 
of integrin clusters, marked by large fluorescent islands with a cross-sectional area of 
approximately 0.8 μm2 (Figure 5.9a and 5.9c). Almost no integrin clusters were observed within 
cells cultured in a static condition (Figure 5.9a and 5.9c). In addition, no significant integrin cluster 
formation was visualized with cells cultured at ΦFBS of 1%. Overall, the iron content per cell, 
modulated by the orbital flow velocity and ΦFBS, could be related to the degree of intracellular 
integrin cluster formation but not to the total integrin expression level. 
 
5.2.5 Stem cell labeling under shaking for in vitro and in vivo imaging  
Finally, we evaluated whether this labeling protocol would generate different levels of MR 
contrast both in vitro and in vivo. According to MR images of BMSCs loaded in a tissue-like 3D 
collagen gel, the largest degree of negative contrast, or hypointensity, was observed in gels 
containing cells labeled with RGD-SPION clusters at 50 rpm and ΦFBS of 10% (Figure 5.10a and 
5.10b). Similarly, the inverse of T2 (1/T2) of each gel, calculated with an array of echo times, was 
highest for BMSCs labeled at 50 rpm and ΦFBS of 10% (Figure 5.10c). A larger 1/T2 value 
represents a greater amount of RGD-SPION clusters per cell, as confirmed with the highly linear 
relationship between 1/T2 and iron content per cell (Figure 5.10d). 
Lastly, we injected BMSCs labeled under static and shaking conditions into the right hindlimb 
of a mouse (Figure 5.11a). Injecting stem cells in this manner is often used to treat ischemia.27 The 
concentration of FBS in the cell culture media was kept constant at 10%, and BMSCs were only 
labeled at static conditions and at 50 rpm. Unlabeled BMSCs were used as a control. A hindlimb 
injected with BMSCs labeled under orbital flow displayed a greater degree of hypointensity than 
a hindlimb injected with cells labeled in the static condition (Figure 5.11b-II and 5.11b-III). This 
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hypointense area was more localized by injecting a collagen gel loaded with BMSCs labeled at 50 
rpm (Figure 5.11b-IV). No noticeable hypointense region was observed in hindlimbs injected with 
unlabeled BMSCs (Figure 5.11b-I). 
 
5.3 Discussion  
Taken together, we have successfully demonstrated that the extracellular mechanical 
environment plays an important role in stem cell labeling with MR contrast agents. The use of 
mechanical stimuli to control cell labeling is unique, as previous attempts to improve SPION 
uptake in stem cells were based mostly on the surface modification of SPIONs. In early attempts, 
researchers added a cell-penetrating peptide28 (such as HIV-tat) or a transfection agent (such as 
Lipofectamine or poly l-lysine)29 to the SPION surface to improve SPION loading per cell. More 
recently, researchers explored a variety of polymer coatings on the SPION surface in order to 
enhance cellular uptake. For example, a layer-by-layer electrostatic assembly technique was used 
to introduce polyethyleneimine, chitosan, dextran, and other polymers to the SPION surface.30 
Another alternative technique coated the SPION surface with a layer of silica, allowing a variety 
of functional groups to be conjugated on the silica–SPION surface.31 However, concerns have been 
raised over the cytotoxicity and overall usefulness of these methods. For example, HIV-tat coated 
SPIONs located specifically to the nucleus, which might interfere with cellular function and 
differentiation.28 In addition, the introduction of new coatings on the SPION surface requires a 
laborious chemical synthesis and subsequent purification. Our labeling technique, on the other 
hand, requires a one-step method to prepare the RGD-SPION clusters, relies on nonchemical 
methods to improve SPION uptake, and maintains cell viability in a variety of cellular 
environments. 
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When compared to other methods to externally stimulate SPION uptake, our labeling technique 
again has noticeable advantages. Previously reported external techniques to enhance cell labeling 
included electroporation13 or the use of a piezoactuator. However, these methods have been shown 
to compromise cell viability32 and can be technically challenging.33 In contrast, our cell labeling 
procedure only requires an orbital shaker, which is an inexpensive, easy-to-use piece of equipment 
readily available in research laboratories and operation rooms. One shaker can contain several 
flasks, allowing for millions of cells to be labeled simultaneously. In addition, orbital shaking has 
no significant effect on cell viability. Improvements to this protocol can be made to enable highly 
effective stem cell labeling. For example, we suggest that cells labeled by advanced SPION 
systems with high T2 relaxivity (e.g., 700 mM
–1s–1) under orbital shaking would further improve 
stem cell tracking quality. 
To better understand this protocol, we explored the changes in cell–nanoparticle interaction 
and cell phenotype that occurred under shaking. Initially, we hypothesized that the cellular uptake 
of RGD-SPION clusters was dependent on both average particle velocity and shear stress on the 
cell membrane. However, a considerable increase in iron content per cell was discovered for 
BMSC labeling at 20 rpm, where only shear stress was significantly increased. This trend 
suggested that mechanotransduction played a more significant role in regulating the cellular uptake 
of nanoparticle clusters than changes in average cluster velocity. The continued increase of the 
iron content per cell from 20 to 50 rpm likely resulted from a larger magnitude of mechanical 
stimulation. Further mechanistic studies on cellular division, integrin expression, and integrin 
cluster formation demonstrated that the mechanism by which the shear stress increased cellular 
SPION cluster uptake was likely related to integrin cluster upregulation, a known intermediary 
step in integrin-mediated endocytosis. Additionally, we demonstrated that serum was an important 
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element to switch on cellular mechanosensitivity, as confirmed with the minimal dependency of 
RGD-SPION cluster uptake on orbital flow in low serum conditions. However, further work will 
be necessary to fully understand the specific endocytotic pathway. 
 
5.4 Conclusion 
In conclusion, this study offers the first step in a new, nonchemical method for simple but 
elaborate stem cell labeling based on manipulating the extracellular mechanical environment. We 
believe that this flow-modulated cell labeling procedure will greatly benefit MR-based cell 
tracking, as this method avoids the laborious chemical modifications and carefully refined 
protocols found in previous studies. Previous studies demonstrated that external shear flow 
influences cellular uptake of gene complexes and nanoparticles (e.g., quantum dot and silica 
nanoparticles) in microfluidic systems.34 However, this is the first study to demonstrate that shear 
conditions readily modulated by a conventional orbital shaker can stimulate efficient mesenchymal 
stem cell labeling with SPIONs. Unlike complex microfluidic systems, an orbital shaker is readily 
available in clinical settings for cell labeling. Therefore, we believe that this protocol would be 
useful for labeling a wide array of stem cells and islets35 with SPIONs for diagnosing and treating 
various diseases and tissue defects. We suggest that the effects of external flow on cell labeling 
would be further amplified by tailoring other external extracellular environmental factors such as 
cell adhesion ligands, cell adherent matrix stiffness, and growth factors in media.36 Finally, we 
envision that this method would be readily utilized for improving the cellular uptake of exogenous 
genes (e.g., siRNA and DNA) as well as other nanoparticles used for imaging and treatments.37 
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5.5 Materials and Methods 
Materials were purchased from Sigma Aldrich unless otherwise specified. 
 
5.5.1 Synthesis of oleic acid-coated superparamagnetic iron oxide nanoparticles (OA-SPIONs) 
Five nm diameter iron oxide nanoparticles were prepared from the thermal decomposition of 
iron acetylacetonate.18 First, a three-neck flask was charged with 0.2 g of iron acetylacetonate, 660 
μL of oleic acid, 600 μL of oleylamine, and 0.7 g of 1,2-dodecanediol. All compounds were 
dissolved in 6.7 mL of benzyl ether. Under nitrogen flow, the mixture was heated to 200 °C for 2 
h and then slowly heated up to 300 °C under reflux for 1 h with gentle stirring. To purify the 
SPIONs, the reaction mixture was precipitated with ethanol (Declon) and then magnetically 
separated (K & J Magnetics). These oleic acid-coated SPIONs (termed “OA-SPIONs”) were 
finally dispersed in chloroform at 10 mg/mL and stored at −20 °C until further analysis. 
 
5.5.2 Synthesis of polysuccinimide 
Polysuccinimide (PSI) was prepared from the thermal condensation of aspartic acid, as 
previously reported.38 In a two-neck flask, 25 g of aspartic acid was dissolved in the presence of 
125 mL of mesitylene and 125 mL of sulfolane. The mixture was heated to 180 °C under nitrogen, 
and then, 240 μL of phosphoric acid was injected to catalyze the reaction. The reaction was run 
overnight, after which the reaction mixture was vacuum filtered, washed thoroughly with methanol 
and water, and then lyophilized. 
 
 
112 
 
5.5.3 Synthesis of PHEA substituted with octadecyl chains (C18) and RGD peptides (RGD-PHEA-
C18) 
To prepare RGD-PHEA-C18, 0.4 g of PSI was dissolved in 10 mL of dimethylformamide 
(DMF). Then, 59 mg of octadecylamine was added to this mixture and reacted overnight. 
Afterward, 32 mg of GGGGRGDSP (Mimotope Peptide) was added to the mixture and then 
reacted for 5 h, followed by 1 mL of ethanolamine for 3 h. All reaction steps were completed under 
nitrogen at room temperature in water-free conditions. After completion, the reaction mixture was 
added to a dialysis bag (MWCO 3,500; Fisher) and then dialyzed against DI water for 48 h, while 
adding fresh water at least four times. NaCl was added to water for the first round of dialysis. 
Afterward, the product was frozen and then lyophilized (Labconco) for 48 h to obtain a dried 
product. Total yield ranged from 70 to 90%. 1H NMR (Varian VXR 500 with Unity Inova Console) 
was used to analyze the product dissolved in DMSO-d6. For accurate shimming, the temperature 
of the NMR probe was greater than 30 °C. 
 
5.5.4 Quantification of octadecyl chain engraftment to PHEA 
Using 1H NMR and an established protocol,17 the degree of octadecylamine substitution 
(DSC18) was quantified by the following equation: 
𝐷𝑆𝐶18 =
𝑝𝑒𝑎𝑘 𝑖𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑖𝑜𝑛 𝑓𝑟𝑜𝑚 0.8 𝑡𝑜 0.9 𝑝𝑝𝑚
3(𝑝𝑒𝑎𝑘 𝑖𝑛𝑡𝑒𝑔𝑟𝑎𝑡𝑖𝑜𝑛 𝑓𝑟𝑜𝑚 4.3 𝑡𝑜 4.7 𝑝𝑝𝑚)
× 100%     (5.2) 
 
5.5.5 Preparation of SPION clusters with RGD-PHEA-C18 
To prepare RGD-SPION clusters, 400 μL of 5 mg/mL OA-SPIONs suspended in chloroform 
was added to 8 mL of 5 mg/mL RGD-PHEA-C18 in DI water. The mixture was quickly sonicated 
(Fisher Scientific) in order to form a cloudy suspension. Using a rotary evaporator (Heidolph), the 
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chloroform phase was removed from the suspension after about 20 min. The concentrated RGD-
SPION cluster suspension was first transferred to a centrifuge tube and then centrifuged at 4000 
rpm for 10 min (Eppendorf 5180R). Afterward, the supernatant was collected. By collecting the 
supernatant, sediments containing nonencapsulated and unstable SPIONs were removed and then 
discarded. In this way, we could only retain stable RGD-SPION clusters for further purification. 
Next, to remove free RGD-PHEA-C18, the supernatant was centrifuged at 15 000 rpm for 20 min 
(Eppendorf 5424), allowing RGD-SPION clusters to be separated out. Finally, RGD-SPION 
clusters were reconstituted in Dulbecco’s modified Eagle’s medium (DMEM, Corning Cellgro) 
with gentle bath sonication (Fisher) and stored at 4 °C until further usage. 
 
5.5.6 Analysis of iron content in RGD-SPION clusters and cells 
Iron content in RGD-SPION clusters and in BMSCs was quantified through inductively 
coupled plasma spectrometry (ICP, Perkinelmer 2000 DV). All samples were dissolved in nitric 
acid (Macron) and then diluted to 5 mL with DI water. NIST primary standards were used for 
instrument calibration. Samples were fed into the instrument with a peristaltic pump, and an 
internal standard was used to account for variations in sample fluidity. 
 
5.5.7 Measurement of RGD-SPION size with dynamic light scattering (DLS) 
After purification, RGD-SPION clusters were redispersed at a dilute concentration and then 
analyzed with dynamic light scattering (Malvern Zetasizer). At least three measurements were 
made, and RGD-SPION cluster diameter was reported as the peak of the number distribution. 
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5.5.8 Image analysis of OA-SPIONs and RGD-SPION clusters 
OA-SPIONs and RGD-SPION clusters were visualized with transmission electron microscopy 
(TEM). The samples were air-dried on a holey carbon-coated grid and then imaged at 200 kV 
(JEOL 2100 TEM). To determine the diameter of the OA-SPIONs, at least 50 particles were 
analyzed using ImageJ software. 
 
5.5.9 Analysis of magnetic resonance (MR) relaxivity of SPION clusters 
MR relaxivity of RGD-SPION clusters was measured using a spin–echo sequence (14.1 T 
Varian MR system). Prior to imaging, the instrument was shimmed with a single-pulse sequence 
until line width was around 600 Hz. Imaging parameters included receiver gain: 44; repetition time 
(trepetition): 300 ms; echo time (techo): 9, 10, 11,12, 13, 14 ms; data matrix: 256 × 256; field of view: 
30 × 30 mm; slice thickness varied as needed. Total acquisition time was between 10 and 20 min, 
and a copper sulfate solution was used as a marker. To calculate T2 values, the mean gray value 
(termed “relative brightness”) from ImageJ was plotted against echo time. Using an exponential 
fit, the inverse of T2 was calculated. T2 relaxivity was quantified from the slope of the curve 
between the inverse T2 and iron concentration. For relaxivity measurements, at least five different 
iron concentrations were used. 
 
5.5.10 BMSC culture 
Mouse bone marrow-derived D1 mesenchymal stem cells (ATCC) were cultured in DMEM 
(Corning Cellgro) supplemented with 10% fetal bovine serum (Thermo Scientific) and 1% 
penicillin/streptomycin (Gibco). Cells were incubated at 5% CO2 and 37 °C in sterile conditions. 
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Cell media was changed every 3 days, and cells were passaged when over 90% confluent. No 
passage numbers higher than 28 were used. 
 
5.5.11 Coincubation of cells with RGD-SPION clusters 
BMSCs were plated in T-25 cell culture flasks at a density of 10,000 cells/cm2 and then 
incubated overnight. Afterward, fresh DMEM supplemented with 10% or 1% FBS was added, and 
then, the cell culture flasks were placed on an orbital shaker set to rotate at 0, 20, or 50 rpm 
(Heidolph Rotamax 120). The cell culture flasks were shaken for approximately 10 h to allow cells 
to adapt to their new environment. In previous studies, at least 6 h was necessary for noticeable 
cellular gene expression changes to take place under shear. After 10 h of continuous shaking, 
media was removed, and fresh media containing RGD-SPION clusters at a concentration of 0.32 
mM Fe was added. Once again, FBS concentration was kept consistent at either 10% or 1%. Then, 
cells were exposed to orbital flow and RGD-SPION clusters for the next 14 h. After incubation, 
cells were washed three times with PBS to remove free RGD-SPION clusters. In parallel, cells in 
a stationary flask were incubated for 10 h without RGD-SPION clusters and then for 14 h with 
media containing RGD-SPION clusters at a concentration of 0.32 mM Fe, again with a constant 
FBS concentration. Unlabeled cells incubated for 24 h in a stationary flask at an FBS concentration 
of 10% served as a control. 
 
5.5.12 Phase contrast imaging of cells incubated with SPION clusters 
Following coincubation of BMSCs with RGD-SPION clusters, cells were fixed with 3.7% 
paraformaldehyde in phosphate buffer saline (PBS) for 30 min. After washing with PBS, Perls 
reagent (1:1 10% potassium ferrocyanide/1 N HCl) was added for 20 min. In this step, poisonous 
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hydrogen cyanide is liberated. Then, cells were washed thoroughly with PBS. Images were taken 
with a Zeiss Axiovert 200 M apotome microscope at 20× and 63×. 
 
5.5.13 ICP analysis of cellular uptake of RGD-SPION clusters 
After coincubation with RGD-SPION clusters, cells were washed, trypsinized, counted, and 
then centrifuged to form a pellet. The pellet was dissolved in concentrated nitric acid overnight at 
room temperature before analysis. ICP measurements were taken as previously described. At least 
three aliquots containing 100 000 cells each were used for each sample for ICP analysis. 
 
5.5.14 MR imaging of cells labeled with RGD-SPION clusters 
After coincubation with RGD-SPION clusters, cells were washed, trypsinized, and then 
resuspended in DMEM at 1 × 106 cells/mL. Cells were then embedded in bovine type I collagen 
gel (PureCol, Advanced Biomatrix) by mixing cells with collagen solution and then increasing pH 
and temperature to form a gel, as previously reported.39 Care was taken to avoid air bubbles in the 
viscous collagen suspension, and the gels were formed within a glass capillary tube at 37 °C. The 
total concentration of cells in the pregelled solution was approximately 300 cells/μL. After 
embedding, labeled BMSCs were imaged with a 14.1 T Varian MR system using a spin–echo 
sequence. Prior to imaging, the instrument was shimmed using a single pulse sequence until line 
width was less than 600 Hz. MR imaging parameters were as follows: receiver gain: 44; trepetition: 
300 ms; techo: 1, 2, 4, 6, 8, 10 ms; data matrix: 256 × 256; field of view: 30 × 30 mm. Total 
acquisition time ranged from 10 to 20 min, and a copper sulfate solution was used as a marker. To 
quantify a mean T2 value per condition, at least two 0.7 mm thick slices were selected in different 
locations of each gel. 
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5.5.15 Analysis of cell viability following cellular uptake of RGD-SPION clusters 
The viability of BMSCs incubated with RGD-SPION clusters in static or dynamic conditions 
was assessed with a Trypan Blue and a 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium 
bromide (MTT) reagent assay (ATCC). For Trypan Blue assays, cells were washed with PBS and 
then incubated with 0.4% Trypan Blue for 5 min. Then, the percentage of live cells was counted 
using a light microscope (Leica). For the MTT assay, 10 μL of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide was added to 100 μL of phenol red-free DMEM with cells and 
incubated at 37 °C for 4 h. Then, cells were digested in 100 μL of detergent for 2.5 h. Absorbance 
of cell lysate was read at 570 nm (BioTek Synergy HT). 
 
5.5.16 Immunostaining of β1 integrins 
Cells were fixed with 3.7% paraformaldehyde for 10 min. After washing cells with PBS, 
samples were incubated with 1% bovine serum albumin, 5% FBS, and 0.3% Triton-X for 1 h to 
block nonspecific binding and permeabilize cells. Then, cells were incubated with a mouse 
monoclonal antibody to integrin β1 (Abcam) overnight at 4 °C. After washing, cells were incubated 
with goat polycloncal 6563 secondary anitbody-Cy5 (Abcam) for 1 h at room temperature. 
Dilution ratios were 1:1000 for both the primary and secondary antibodies. Lastly, 4′,6-diamidino-
2-phenylindole dihydrochloride (DAPI, Invitrogen) was used to stain cell nuclei at a working 
concentration of 100 ng/mL. 
Nuclei and cellular integrins were imaged using a Zeiss LSM 700 confocal microscope at 40×. 
ImageJ software was used to quantify the integrin expression level and integrin cluster formation. 
Each image was separated into three channels, and the mean gray value of the green channel 
(termed “mean green value”) was determined over the cell area. Here, a higher mean green value 
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corresponds to a higher relative level of integrin expression. At least 15 cells were analyzed per 
condition. 
 
5.5.17 Intramuscular hindlimb injection of labeled BMSCs into a mouse model 
All mice work was carried out in accordance with university and federal regulations 
(Institutional Animal Care and Use Committee approval number: 11089). We used three four 
month old Balb/c and two three month old C57Black mice for our in vivo work. Before cell 
injection, all mice were anesthetized with isoflurane. Then, a 50 μL BMSC suspension (2 × 106 
cells/mL) was injected into the muscles of the right caudal thigh approximately between 
semimembranosus and semitendinosus muscles, using a 1.0 mL syringe with 25G1 needle. BMSCs 
labeled in static conditions or at 50 rpm were used in this study, and unlabeled BMSCs were used 
as a negative control. To help localize the hypointense area, cells labeled at 50 rpm were mixed 
with 1 mg/mL of type I collagen prior to injection. 
 
5.5.18 In Vivo MR-based tracking of BMSCs 
Mice were humanely sacrificed approximately 1 h after injection. Then, both legs of each 
mouse were imaged with a spin–echo sequence (14.1 T Varian MR system) to locate the 
transplanted BMSCs. A custom-built coil was used to contain the sacrificed mice, the details of 
which are described elsewhere.40 Prior to imaging, the instrument was shimmed manually until 
line width was around 200 Hz. Imaging parameters include trepetition: 1000–1300 ms; techo: 40 ms; 
data matrix: 256 × 256; slice thickness: 0.5–1.0 mm; field of view varied as needed. Coronal cuts 
were used to identify the hypointense regions, which were subsequently processed in ImageJ. Total 
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acquisition time was around 20 min, and a copper sulfate solution was used as a marker. Afterward, 
mouse bodies were disposed of according to university regulations. 
 
5.5.19 Computational simulation of average RGD-SPION cluster velocity 
The particle motion in unsteady, free-surface flow inside a 25 mm2 cell culture flask was 
simulated using finite element method (FEM) commercial software (COMSOL Multiphysics 3.3). 
To begin this analysis, 4 mL of media rotated at three different speeds (f) of 0, 20, and 50 rpm was 
simulated. Then, the free surface motion in the liquid–air interface and the particle flow patterns 
inside the well were analyzed. The orbital shaker imparts the same two-dimensional, in-plane 
movement to all points on the plate. The velocity of the plate walls (U) is thus given by:  
          (5.3) 
where Rg is the orbital radius (∼20 mm in this study) and Ω is the angular velocity that is given 
by 
Ω = 2𝜋𝑓            (5.4) 
 
5.5.20 Statistical analysis 
All data were analyzed using a two-tailed t test with equal variance (Microsoft Excel). P < 0.05 
was considered the threshold for significance. All samples were done in triplicate unless otherwise 
noted. Data are represented as mean + standard error of mean (SEM). 
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5.6 Figures  
 
Figure 5.1 1H-NMR spectrum of polysuccinimide. 
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Figure 5.2 1H-NMR spectrum of RGD-PHEA-C18 
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Figure 5.3 Characterization of RGD-PHEA-C18 and RGD-SPION cluster. (a) Structure of RGD-
PHEA-C18. (b) TEM image of oleic acid-coated SPIONs. (c) TEM image of RGD-SPION 
clusters. Both scale bars represent 50 nm. (d) OA-coated SPIONs (I) are suspended in hexane, 
while RGD-SPION clusters (II) are dispersed in water. Dotted white lines help indicate the 
interface between hexane and water. (e) A plot of 1/T2 vs iron concentration used to determine T2 
relaxivity of RGD-SPION clusters. 
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Figure 5.4 Size distribution for RGD-SPION clusters as characterized by DLS. A blue dotted 
line is noted at 50 nm, which is considered the upper limit for receptor-mediated endocytosis. 
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Figure 5.5 Computation analysis of particle movement in T25 culture flask. Average particle 
velocity with different rotational speeds. 
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Figure 5.6 Maximum shear stress at the bottom of a T25 flask with rotation speeds.  
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Figure 5.7 Analysis of the effect of orbital velocity on cellular uptake of RGD-SPION clusters at 
varied FBS concentrations (ΦFBS). (a) Phase contrast images of BMSCs labeled at various 
conditions. Prussian blue stain indicates the presence of iron. (a-I) BMSCs labeled with RGD-
SPION clusters under static conditions (ΦFBS = 10%), (a-II) BMSCs labeled with RGD-SPION 
clusters at 50 rpm (ΦFBS = 10%), (a-III) BMSCs labeled with RGD-SPION clusters under static 
conditions (ΦFBS = 1%), and (a-IV) BMSCs labeled with RGD-SPION clusters at 50 rpm (ΦFBS 
= 1%). Scale bars represent 40 μm. The images on the 2nd column in (a) are magnified images of 
cells from the same condition in the 1st column. Orange arrows indicate RGD-SPION clusters 
stained by Prussian blue, and white dotted lines indicate cellular periphery. (b) ICP analysis to 
quantify the dependence of the iron content per cell on orbital velocity at ΦFBS of 10%. 
Differences of values between conditions were statistically significant (*p < 0.05). (c) ICP analysis 
to show the independence of the iron content per cell on orbital velocity at ΦFBS of 1%. 
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Figure 5.8. Changes in cell proliferation for different orbital velocities and FBS concentrations. 
Here, greater absorbance values correspond to a greater degree of metabolic activity. The 
difference of values between conditions is statistically significant (*p<0.05).  
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Figure 5.9 Analysis of the effects of orbital velocity on cellular integrin expression and integrin 
cluster formation at varied FBS concentrations (ΦFBS). (a) Confocal images of β1 integrins (green 
color) and nuclei (blue color). The orange arrows mark β1 integrin clusters, and red scale bars 
correspond to 20 μm. (b) Quantification of the number of green-colored pixels (“Mean Green 
Value”), indicative of total β1 integrin expression. The difference of values between ΦFBS of 10% 
and 1% was statistically significant. ∗∗ corresponds to p < 0.01. (c) Analysis of the cross-sectional 
area of β1 integrin clusters. 
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Figure 5.10 In vitro analysis of T2 for SPIO-labeled BMSCs in a collagen gel. (a) Schematic 
describing in vitro MR imaging of BMSCs encapsulated in a collagen gel formed inside a glass 
tube. (b) Slices of collagen gels with labeled BMSCs imaged with a spin–echo sequence. (c) 
Effects of orbital velocity on the inverse T2, at varied FBS concentrations in the cell culture 
media. The difference of values between BMSCs incubated with RGD-SPION clusters in static 
condition and those exposed to orbital flow at velocity of 50 rpm is statically significant (*p < 
0.05). (d) The linear dependency of the inverse T2 per 105 cells on the iron content per cell 
measured with ICP (R2 > 0.8). 
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Figure 5.11 In vivo MR images of BMSCs injected into the muscle of a mouse’s hindlimb. (a) 
Schematic describing hindlimb injection with labeled BMSCs. (b) MR images of both hindlimbs. 
The BMSCs were injected into the right hindlimb, as indicted with the red arrows. (b-I) 
Hindlimb transplanted with unlabeled BMSCs, (b-II) hindlimb transplanted with BMSCs labeled 
under static conditions, (b-III) hindlimb transplanted with BMSCs labeled at 50 rpm, and (b-IV) 
hindlimb implanted with a BMSCs labeled at 50 rpm and then encapsulated in collagen gel in 
situ. In (b), images of the 2nd row are magnified views of the right hindlimb. Orange arrows in 
the 2nd row images point to the hypointense area due to the presence of transplanted cells. 
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CHAPTER 6: VITAMIN E-LOADED NANOCARRIERS TO TREAT 
CARDIOVASCULAR DISEASE5 
 
6.1 Introduction  
In recent years, the use of self-assembled polymeric nanocarriers for drug delivery has been 
extensively explored. These nanocarriers can be tailored to actively or passively target different 
diseased tissues, and can package a variety of hydrophilic or hydrophobic molecules.1 By 
modifying the polymer structure prior to self-assembly, the nanocarriers can be made to actively 
release their cargos in response to a specific in vivo or external event.2 Despite significant efforts 
in this area, concern remains over the encapsulation efficiency and targetability of these 
nanocarriers.3,4 Nanocarriers with a low encapsulation efficiency and nonspecific targetability to 
tissues will deliver a dose too low to be effective, in turn offering little improvement over 
systemic, “shotgun-style” drug delivery. Of particular concern is the delivery of hydrophobic 
molecules via polymeric nanocarriers. Poorly water soluble molecules may have a reduced half-
life or altered transport in the body, and solubility is a significant issue in new drug 
development.5 Moreover, methods to effectively incorporate the hydrophobic molecules into a 
water-stable nanocarrier are lacking.   
To this end, we hypothesized that an amphiphilic poly(2-hydroxyethyl)aspartamide (PHEA) 
polymer substituted with octadecyl chains (C18) and amine groups (termed “NH2-PHEA-C18”)  
could be used to prepare self-assembled nanocarriers which encapsulate alpha-tocopherol 
(vitamin E) in a highly efficient manner. We proposed that this structure would be similar to that 
of chylomicrons, nano-sized transporters of vitamin E that exist in the body and deliver vitamin 
                                                     
5 I would like to thank Dr. Binxia Yang and Dr. Sanjay Misra for their assistance with the animal studies done at the 
Mayo Clinic. I would like to also thank Julio Serrano from the Zimmerman Lab (UIUC) for assistance as well.  
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E from the intestine to the liver.6 A solution of NH2-PHEA-C18 was dissolved in 
dimethylformamide (DMF) in the presence of vitamin E, and then precipitated with the dropwise 
addition of water. The amount of octadecyl chains was controlled to change the stability and size 
of the resulting nanocarriers. The morphology of the nanocarriers was analyzed with 
transmission electron microscopy (TEM). The thermodynamic stability of the nanocarriers was 
analyzed by comparing the fraction of vitamin E encapsulated in the nanocarriers to the fraction 
of vitamin E not encapsulated. Nanocarriers were then prepared with controlled numbers of 
vascular cell adhesion molecule (VCAM)-binding peptides, and nanocarrier adhesion to an 
inflamed cell surface was studied. Overall, we believe this bioinspired approach will serve to 
improve the delivery of small, extremely-hydrophobic molecules to different tissues, in addition 
to elucidating different nanoparticle assembly processes. 
 
6.2 Results  
Starting from the aminolysis of polyaspartamide, controlled numbers of octadecyl chains and 
amine groups were grafted to polysuccinimide to create an amphiphilic polyaspartamide (termed 
“NH2-PHEA-C18”) (Figure 6.1).7 The degree of substitution of octadecyl chain (DSC18) was 
approximated using equation 6.1: 
𝐷𝑆𝐶18 =
𝐴𝑟𝑒𝑎  𝑓𝑟𝑜𝑚 0.8 𝑡𝑜 0.94 𝑝𝑝𝑚
(𝐴𝑟𝑒𝑎 𝑓𝑟𝑜𝑚 4.3 𝑡𝑜 4.6 𝑝𝑝𝑚)∗3
× 100%                                          (6.1) 
By varying the mass ratio of octadecyl chain to polysuccinimide in the aminolysis reaction, 
DSC18 was varied from 2 % to 10 %.  
Using a dropwise precipitation reaction, polyaspartamide nanocarriers loaded with vitamin E 
were created and then imaged with TEM (Figure 6.2). Interestingly, increasing DSC18 from 2 % to 
10 % resulted in a decrease in nanocarrier diameter from approximately 1 µm to 380 nm. Most 
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importantly, for NH2-PHEA-C18 (DSC18 of 10 %), the nanocarrier size range is approximately 
within the size range of chylomicrons.8 Chylomicrons are nano-sized components which help 
transport vitamin E from the intestine to the liver. Therefore, the nanocarriers prepared with NH2-
PHEA-C18 (DSC18 of 10 %) will likely be most suitable for delivering vitamin E in vivo. Without 
the addition of an octadecyl chain (DSC18 of 0 %), no nanocarriers were realized in TEM images 
(Figure 6.1) In addition, no nanocarriers were formed by precipitating a solution of NH2-PHEA-
C18 without vitamin E (Figure 6.3). 
The stability of the vitamin E-loaded nanocarriers was first assessed visually (Figure 6.4a). 
Without the presence of an octadecyl chain, vitamin E almost completely separated from the 
aqueous solution over the course of one day, as the vitamin E dispersion turns from cloudy to clear 
(Figure 6.4bi and 6.4bii). On the other hand, for nanocarriers made with NH2-PHEA-C18 polymers 
with DSC18 of 2 % and 10%, a cloudy dispersion remains stable over the course of one day (Figure 
6.4biii and 6.4biv).   
To quantify the thermodynamic stability of the vitamin E-loaded nanocarriers, the amount of 
vitamin E which was not stably dispersed in aqueous conditions was measured. Using equation 
6.2, 6.3 and 6.4, the enthalpy of separation (ΔHsep), the entropy of separation (ΔSsep), and the Gibbs 
free energy of separation (ΔGsep) were calculated (Figure 6.4c). Notably, ΔGsep is negative for the 
dispersions prepared without an octadecyl chain, and positive for the dispersions prepared with an 
octadecyl chain. This trend suggests that the octadecyl chain plays a key role in ensuring the 
complete dispersion of vitamin E in aqueous conditions, and that the separation of vitamin E from 
water is nonspontaneous for nanocarriers made from NH2-PHEA-C18 with DSC18 of 2 % and NH2-
PHEA-C18 with DSC18 of 10%. In contrast, the vitamin E dispersions prepared without an octadecyl 
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chain are unstable, and are driven to separate from water, as realized by the negative value of 
ΔGsep.  
Interestingly, the ΔSsep values were significantly more positive for the dispersions prepared 
without the octadecyl chain than those for the dispersions prepared with the octadecyl chain, 
suggesting that vitamin E phase separation corresponds with an increase in disorder of the 
dispersion. With no amphiphilic polymer to stabilize vitamin E in an aqueous solution, a highly 
ordered network of hydrogen bonded water molecules likely formed around each vitamin E 
molecule in solution. As these aggregates coalesce and separate from water, this ordered hydrogen 
bond network disappeared, thus dramatically increasing the entropy of the system.9  
Next, the adhesion of the vitamin E nanocarriers to an inflamed cell monolayer was measured 
(Figure 6.5a).10 Nanocarriers were prepared from the drop-wise precipitation of a solution 
containing VCAM-PHEA-C18, NH2-PHEA-C18, and vitamin E. In these solutions, the mass ratio 
of VCAM-PHEA-C18 and NH2-PHEA-C18 was varied from 0, 0.1111, 0.166667, and 0.3333. The 
total mass concentration of both polymers in the solutions was 15 mg/mL, and both polymers had 
a DSC18 of 10%. In this manner, the density of VCAM-binding peptides was kept low to avoid any 
interference with the nanocarrier self-assembly process. Interestingly, for the nanocarriers 
prepared with no VCAM-binding peptide, a significant amount of non-specific adhesion to the 
inflamed monolayer was realized, as determined by the high relative fluorescent intensity of the 
monolayer after incubation with nanocarriers (Figure 6.5b). The lowest amount of adhesion occurs 
when the nanocarrier has the lowest amount of VCAM peptide on the surface. As the mass ratio 
of VCAM-PHEA-C18 to NH2-PHEA-C18 increased from 0.1111 to 0.333, adhesion to the inflamed 
monolayer increased as well.  
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The presence of non-specific adhesion is likely due in part to the structure of the PHEA 
polymer used to prepare the nanocarriers. The hydrophobic and hydrophilic monomers in NH2-
PHEA-C18 and VCAM-PHEA-C18 are randomly distributed relative to one another, thus forming 
a statistical copolymer. Therefore, while a majority of the octadecyl chains will self-associate with 
the vitamin E in the interior of the nanocarrier, a fraction of chains will likely protrude from the 
nanocarrier surface. These chains may insert into the membrane of cells, thus providing a 
competing mechanism for cell adhesion, even with no VCAM-binding peptide present.11  
The surface charge of the nanocarriers is independent of the amount of VCAM on the surface 
(Figure 6.6). In addition, the nanocarriers have a slightly negative charge, and any effect of charge 
on cell adhesion is minimal. 
 
6.3 Conclusion  
With this study, we have demonstrated the preparation of a vitamin E-loaded nanocarrier. By 
adding an octadecyl chain to a polyaspartamide polymer, hydrophobic vitamin E can be kept 
thermodynamically stable in an aqueous dispersion. The size of the nanocarrier can be further 
reduced by increasing the relative amount of octadecyl chain added to it, thus producing 
nanocarriers that are in the size range of the natural, in vivo carriers of vitamin E such as 
chylomicrons. In this manner, we have demonstrated a bioinspired approach to nanocarrier 
fabrication. Further studies will consider methods to improve the targeting capabilities of these 
nanocarriers. Moreover, in vivo studies to treat oxidative stress-mediated diseases will be 
considered as well.  
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6.4 Materials and Methods  
All chemicals were purchased from Sigma-Aldrich and used without purification, unless 
otherwise stated. All water was high-pressure liquid chromatography (HPLC) grade water 
(Macron), unless stated otherwise.  
 
6.4.1 Synthesis of NH2-PHEA-C18 and VCAM-PHEA-C18 
Polysuccinimide (PSI; 19,000 g/mol) was prepared from the acid-catalyzed condensation of 
l-aspartic acid, as previously described (Chapter 4). Approximately 0.47 g of PSI was dissolved 
in dimethylformamide (DMF; ACS grade) at a concentration of 25 mg/mL, and then dissolved at 
70 ˚ C for at least 1 hour. Separately, 0.13 g of octadecylamine was dissolved in 1.5 mL of DMF 
at 70 ˚ C, then quickly added to the PSI solution. The reaction occurred under nitrogen for at 
least 19 h. Afterward, the reaction mixture was cooled to room temperature, and 220 µL of 
ethanolamine was added in a drop-wise fashion. This step of the reaction proceeded for at least 
24 h under nitrogen. Then, a separate solution of diluted ethylenediamine was prepared by 
adding 16 µL of ethylenediamine to 6.8 mL of DMF. For this step, all components were mixed 
under nitrogen, and all glassware was flushed with nitrogen prior to use. Then, the reaction 
mixture was loaded into a syringe, and then added in a dropwise manner to the dilute 
ethylenediamine solution over the course of 15 minutes while stirring. The new reaction mixture 
was then reacted for 3 h at room temperature. After reacting, the mixture was dialyzed again DI 
water (Fisherbrand, 12,000 14,000 MWCO) at least 48 h. Fresh DI water was added at least 6 
times.  
To prepare VCAM-PHEA-C18, the first two reaction steps were repeated as described above. 
After adding octadecylamine and ethanolamine to PSI at the ratios described above, a vascular 
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cell adhesion molecule (VCAM)-binding peptide (sequence: H-VHPKQHRGGSWGC-NH2; 
Mimotope) was added to the reaction mixture at a PSI:peptide mass ratio of 13.4:1.  A separate 
control polymer with no octadecyl chains, no VCAM-binding peptides, and no amines (termed 
“PHEA-OH”) was prepared as well by repeating the only first step of the above reaction.  
 
6.4.2 NMR analysis of NH2-PHEA-C18 and VCAM-PHEA-C18 
NH2-PHEA-C18 was dissolved in d6-DMSO (Cambridge Isotope Laboratory) and then loaded 
into a glass NMR tube. NMR spectra were taken with a Varian VXR 500 at a temperature of at 
least 35 ˚ C. To improve the analyte height, solvent peaks or water peaks were removed as 
needed. All collected spectra were processed using ACDLABS 12.0.  
 
6.4.3 Fabrication of vitamin E-loaded nanocarriers 
A solution of NH2-PHEA-C18 was prepared at 15 mg/mL in DMF. Separately, a mass of α-
tocopherol (vitamin E; 95.5%) was prepared and then mixed with the PHEA polymer solution. 
The concentration of vitamin E in the polymer solution was 43 mg/mL. When not in use, all 
polymer solutions were stored at -20 ˚ C under nitrogen in the dark. Approximately 100 µL of 
the vitamin E/polymer solution was added to a 7 mL glass scintillation vial, and stirred at 1000 
rpm. Then, 1 mL of phosphate buffered saline (PBS; Corning CellGro) was added in a dropwise 
fashion to the polymer solution to form vitamin E-loaded nanocarriers. To remove excess DMF, 
the nanocarrier suspension was collected, and then washed with a centrifugal filter (1500 rcf for 
10 min; Amicon Millipore 100,000 MWCO). After each wash, the nanocarrier suspension was 
redispersed in fresh PBS at a concentration of at least 2 mg/mL. After three washes, the 
nanocarrier suspension was stored at 4 ˚ C for at least 6 weeks.  
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6.4.4 Transmission electron microscopy (TEM) imaging of vitamin E-loaded nanocarriers  
After fabrication and washing, a nanocarrier suspension was diluted to 0.3 to 0.5 mg/mL 
using DI water. Then, approximately 10 to 20 µL of the diluted suspension was quickly added to 
a TEM grid (200 mesh carbon coated, EMS) on top of a piece of filter paper. The grid was then 
air dried for at least 20 minutes and then imaged (JEOL 2100) at 200 kV, with images captured 
at 20,000 X and 40,000 X. As needed, an objective aperture was added to improve the contrast of 
the image. No additional staining was performed. To determine the particle diameter, at least 10 
images per condition were analyzed using Image J (NIH).  
 
6.4.5 Determining thermodynamic stability of Vitamin E-loaded nanocarriers  
To quantify the thermodynamic stability of the vitamin E-loaded nanocarriers, nanocarriers 
were fabricated using the previously described protocol. The polymer used had a DSC18 of 0%, 
2% and 10%. As a control, a 43 mg/mL vitamin E solution in DMF with no polymer was also 
precipitated in PBS in a drop-wise fashion. After precipitating 200 µL into 2 mL of PBS, the 
solutions were then transferred to a 20 mL glass vial and diluted with an additional 2 mL of PBS. 
The precipitated solutions were then allowed to stand overnight at 0, 22, or 37˚C. Afterward, the 
amount of vitamin E separated from solution was weighed. The equilibrium constant (Keq) 
describing was as follows: 
𝐾𝑒𝑞 =
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑣𝑖𝑡𝑎𝑚𝑖𝑛 𝐸 𝑠𝑒𝑝𝑎𝑟𝑎𝑡𝑒𝑑
𝑀𝑎𝑠𝑠 𝑜𝑓 𝑣𝑖𝑡𝑎𝑚𝑖𝑛 𝐸 𝑛𝑜𝑡 𝑠𝑒𝑝𝑎𝑟𝑎𝑡𝑒𝑑
       (6.2) 
From this equation, the enthalpy of separation (∆Hsep) and the entropy of separation (∆Ssep) 
was calculated using the van’t Hoff equation: 
ln 𝐾𝑒𝑞 = −
∆𝐻
𝑅
∗
1
𝑇
+
∆𝑆
𝑅
         (6.3) 
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From here, the Gibbs free energy of separation (∆Gsep) was calculated: 
 ∆𝐺𝑠𝑒𝑝 = ∆𝐻𝑠𝑒𝑝 − 𝑇∆𝑆𝑠𝑒𝑝        (6.4) 
 
6.4.6 Fabrication of rhodamine B-tagged nanocarriers 
Briefly, both VCAM-PHEA-C18 and NH2-PHEA-C18 were dissolved in approximately 6 mL 
of DMF. Then, a solution of Rhodamine B (RBITC) was prepared at 1 mg/mL in dimethyl 
sulfoxide (DMSO). Then, RBITC was added to the PHEA polymer solutions at a mass ratio of 
0.00013:1 RBITC:PHEA. The mixture was stirred at room temperature in the dark for at least 
24h. The mixture was then dialyzed (12,000-14,000 MWCO; Fisherbrand) for 2 days. Fresh DI 
water was added twice. If you’re reading this, thanks for coming this far.  
To prepare nanocarriers with different VCAM densities, VCAM-PHEA-C18 and NH2-PHEA-
C18 were separately dissolved at 30 mg/mL in DMF. Then, the two solutions were mixed at 
different ratios, such that the mass ratio of VCAM-PHEA-C18 to NH2-PHEA-C18 was either 0:1, 
0.11111:1, 0.166667:1, or 0.3333:1. The final polymer concentration was 15 mg/mL in the new 
solution. From there, a mass of vitamin E was added to the polymer solution such that the final 
concentration of vitamin E was 43 mg/mL.  These solutions were purged with nitrogen and then 
stored at -20 ˚C in the dark until further use. A dropwise precipitation protocol was used to 
fabricate the nanocarriers, as previously described.  
 
6.4.7 Analysis of nanocarrier adhesion to inflamed cell monolayer  
C166 cells (ATCC; no passage numbers higher than 20 were used) were seeded in a 96 well 
plate at a density of 50,000 cells/well. After growing for 3 days in fetal bovine serum (FBS)-
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containing cell media, the cell monolayer was then incubated in 100 µL of 40 ng/mL of tumor 
necrosis factor-alpha (TNF-α; GeneScript) in FBS-free media.  
After inflaming the cell monolayer for 24 h, a concentrated volume of vitamin E-loaded 
nanocarriers was added to each well such that the final concentration of nanocarriers (by total 
mass) was 0.5 mg/mL. For the nanocarriers, the mass ratio of VCAM-PHEA-C18 to NH2-PHEA-
C18 was either 0:1, 0.11111:1, 0.166667:1, or 0.3333:1. After incubation for 1 h,  cell monolayers 
were washed several times, and then fixed in 3.7 % paraformaldehyde. The fluorescent intensity 
of each well was measured using a plate reader (Tecan Infinite 200 PRO). Each well was excited 
at 540 nm, and emissions at 580 nm were measured. Gain was set to 80. For each condition, the 
fluorescent intensity per well with nanocarriers was subtracted by the average fluorescent 
intensity of a well with a cell monolayer with no nanocarriers.  
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6.5 Figures  
 
 
 
Figure 6.1 Scheme to prepare amphiphilic polyaspartamide (termed NH2-PHEA-C18). Note that 
the distribution of x, y, and z in the polymer chain is random. 
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Figure 6.2 Transmission electron microscopy (TEM) images of nanocarriers formed from 
polyaspartamide with varying amounts of octadecyl chains. (a) Image of PHEA-OH (DSC18 = 
0%) polymer after drop-wise precipitation. (b) Image of vitamin E-loaded NH2-PHEA-C18 
(DSC18 of 2%) nanocarriers. (c) Image of vitamin E-loaded NH2-PHEA-C18 (DSC18 of 10%) 
nanocarriers. White scale bars correspond to 200 nm. (d) Table depicting average diameter of 
nanocarrier with respect to DSC18. No discernible nanocarriers are present in (a), so a value of 
N/A/ is reported in the table. At least 10 images were analyzed per nanocarrier.  
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Figure 6.3 Transmission electron microscopy (TEM) image depicting NH2-PHEA-C18 (DSC18 of 
20%) polymer after drop-wise precipitation. Scale bar corresponds to 200 nm.  
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Figure 6.4 Thermodynamic stability of vitamin E dispersions with and without an octadecyl 
chain-containing polyaspartamide. (a) Image depicting (i) pure vitamin E dispersed in water 
(N/A); (ii) vitamin E and PHEA-OH (DSC18 of 0%) dispersed in water; (iii) vitamin E-loaded 
NH2-PHEA-C18 (DSC18 of 2 %) nanocarrier dispersed in water; (iv) vitamin E-loaded NH2-
PHEA-C18 (DSC18 of 10 %) nanocarrier dispersed in water. Image was captured immediately 
after fabrication. (b) Image depicting (i) pure vitamin E dispersed in water (N/A); (ii) vitamin E 
and PHEA-OH (DSC18 of 0%) dispersed in water; (iii) vitamin E-loaded NH2-PHEA-C18 (DSC18 
of 2 %) nanocarrier dispersed in water; (iv) vitamin E-loaded NH2-PHEA-C18 (DSC18 of 10 %) 
nanocarrier dispersed in water. Image was captured 24 h after fabrication. (c) Table of Gibbs free 
energy of separation (ΔGsep), enthalpy of separation (ΔHsep), and entropy of separation (ΔSsep) 
with respect to degree of substitution of octadecyl chain. Note that N/A corresponds to the case 
where vitamin E was added to water with no PHEA polymer present.  
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Figure 6.5 Monitoring adhesion of VCAM-binding vitamin E-loaded nanocarriers to an 
inflamed endothelial cell monolayer. (a) Schematic depicting the adhesion of VCAM-binding 
nanocarriers to a monolayer. (b) Relative fluorescent intensity of cell monolayer after incubating 
with nanocarriers with varying amount of VCAM-binding peptides. The mass ratio of PHEA 
polymer with VCAM-binding peptide to PHEA polymer without VCAM-binding peptide was 
varying accordingly. DSC18 was kept constant for both polymers at 10 %. Values represent the 
average of at least 3 samples, and bars represent standard deviation. * corresponds to p<0.05.   
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Figure 6.6 Zeta potential measurements of nanocarriers with VCAM-binding peptides.  
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CHAPTER 7: CONCLUSION 
7.1 Summary  
With the studies included herein, we have demonstrated new techniques to prepare unique 
soft materials for biomedical applications. For ease of processing, we have utilized several self-
assembly approaches throughout.  
For our 3D cell cultures studies, we have tuned the properties of self-assembled collagen gels 
by modulating the hydrogen bond network which stabilizes individual collagen fibers. In turn, 
we prepared hydrogel systems with controllable stiffness and constant hydraulic conductivity. 
With this platform, changes in breast cancer malignancy in response to changes in flow or 
stiffness were examined. Separately, to prepare multifunctional hydrogels, we utilized a 3D 
printing technique to prepare microgels with dual diagnostic and therapeutic functions. It was 
determined that keeping the diagnostic and therapeutic functions separate within the same 
hydrogel prevented any potential interference between the two functions, thus highlighting the 
importance of spatial separation in preparing multifunctional biomaterials.  
This thesis has also examined the preparation of polyaspartamide nanoparticles for different 
diagnostic or therapeutic functions. In doing so, this thesis has contributed significant knowledge 
to the processing techniques used to self-assemble polymeric nanoparticles from amphiphilic 
polymers. By adding a valine chain to an amphiphilic polyaspartamide, polymer solubility in 
organic solvents was dramatically improved. By mixing the resulting polymer solutions into 
water at different rates on a microfluidic chip, micelles with different sizes were prepared. 
Interestingly, as the hydrophobic content of polyaspartamide increased, bilayered polymersomes 
could be formed with turbulent mixing, but not with on-chip mixing.  
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Separately, clusters of polyaspartamide-coated superparamagnetic iron oxide nanoparticles 
were prepared, and then incubated with stem cells. Here, I sought to increase the amount of 
SPION clusters in each cell, thus increasing the MRI signal from the cells. It was determined that 
stem cell labeling under slight mechanical stress led to a greater degree of SPION incorporation 
into the cells, in turn leading to a higher MRI signal per cell.  
By using the same polyaspartamide chemistry, vitamin E-loaded nanocarriers were prepared. 
By tuning the hydrophobic content of polyaspartamide, the size of the nanocarriers was tuned to 
match that of chylomicrons, highly-efficient in vivo transporters of vitamin E.   
 
7.2 Future Work  
The current work on 3D cell culture mostly focused on modulating hydrogen bonding to 
change hydrogel properties. However, additional noncovalent interactions are present in many 
natural or synthetic hydrogels, such as electrostatic interactions. More complex hydrogel systems 
could be envisioned by tuning these noncovalent interactions in addition to tuning hydrogen 
bonding.  For future work in the 3D printing of multifunctional microgels, additional functions 
(for example, tissue adhesion) could be added during the printing process.  
Future nanoparticle work will mostly focus on transitioning to in vivo mouse models. 
Experiments with vitamin E-loaded nanocarriers in mice are currently underway at the Mayo 
Clinic. These nanoparticles will be used to treat venous neointimal hyperplasia (VNH), a chronic 
condition characterized by scar tissue formation in the patient’s veins. Recent evidence suggests 
that this disease may be mediated by the presence of oxidative stress. Therefore, using a vitamin 
E-loaded nanocarrier could control the amount of oxidative stress in vivo, and reduce the 
severity of this disease. Moreover, it may be possible to combine these vitamin E-loaded 
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nanocarriers with SPIONs, in order to provide a dual therapeutic/diagnostic approach to treating 
VNH.  
Overall, the soft material formulations developed in the six studies within this thesis will be 
broadly relevant to a variety of in vivo treatments for different malignant and chronic diseases.  
